<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Psm-3) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">60</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 10168,
    "choices": [
      {
        "id": 40638,
        "text": "<p><span style=\"font-size:12.0pt;\">68%</span></p>"
      },
      {
        "id": 40639,
        "text": "<p><span style=\"font-size:12.0pt;\">34%</span></p>"
      },
      {
        "id": 40640,
        "text": "<p><span style=\"font-size:12.0pt;\">99%</span></p>"
      },
      {
        "id": 40641,
        "text": "<p><span style=\"font-size:12.0pt;\">95%</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What percentage of the distribution corresponds to one standard deviation in a normal curve? (NEET PG 2019)</span></p>",
    "unique_key": "Q3911159",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175026,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 68%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Approximately 68% of the distribution corresponds to one standard deviation in a normal curve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a Normal/Gaussian/Standard Distribution curve,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. B/L Symmetrical Bell shaped curve</span></p><p><span style=\"font-size:12.0pt;\">2. Mean = Median = Mode \u00e0 Known as coincidence</span></p><p><span style=\"font-size:12.0pt;\">3. If Mean = 0 in Normal Distribution, then SD is 1</span></p><p><span style=\"font-size:12.0pt;\">4. Mean \u00b1 1SD \u00e0 Covers 68% value [68.3%]</span></p><p><span style=\"font-size:12.0pt;\">5. Mean \u00b1 2SD \u00e0 Covers 95% value [95.4%]</span></p><p><span style=\"font-size:12.0pt;\">6. Mean \u00b1 3SD \u00e0 Covers 99% value [99.7%]</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-114951.jpg\" alt=\"\" width=\"500\" height=\"315\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Approximately 68% of the data in a normal distribution lies within one standard deviation (\u00b11\u03c3) from the mean.</span></p>",
    "correct_choice_id": 40638,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10199,
    "choices": [
      {
        "id": 40762,
        "text": "<p><span style=\"font-size:12.0pt;\">Oral amoxicillin for five days</span></p>"
      },
      {
        "id": 40763,
        "text": "<p><span style=\"font-size:12.0pt;\">Urgent referral to the tertiary care centre immediately</span></p>"
      },
      {
        "id": 40764,
        "text": "<p><span style=\"font-size:12.0pt;\">Administer IV antibiotics and ask the patient to be brought after 24 hours</span></p>"
      },
      {
        "id": 40765,
        "text": "<p><span style=\"font-size:12.0pt;\">Start antipyretics urgently</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 2-year-old toddler with a weight of 11 kg was brought to the pediatric outpatient department. The child exhibited a respiratory rate of 38 breaths per minute and upon examination, noticeable chest indrawing was detected. What is the next step of management? (NEET PG 2020)</span></p>",
    "unique_key": "Q2971493",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175036,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Oral amoxicillin for five days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the latest revised guidelines by WHO, the management of childhood pneumonia has been updated based on new evidence. In the given scenario, a 2-year-old child presents with a respiratory rate of 38 breaths per minute and chest indrawing, which fits the criteria for pneumonia but without general danger signs. According to the revised classification, the appropriate management for this case is oral amoxicillin for five days and home care advice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Urgent referral to the tertiary care centre immediately</strong>: This is recommended for children showing general danger signs or very severe disease, not for pneumonia with chest indrawing without other danger signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Administer IV antibiotics and ask the patient to be brought after 24 hours</strong>: This would be applicable for severe cases requiring inpatient care, not for managing a case of pneumonia without general danger signs at an outpatient department.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Start antipyretics urgently</strong>: While antipyretics may be used to manage fever, they do not address the underlying pneumonia and are not the primary management step in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-134019.jpg\" alt=\"\" width=\"800\" height=\"346\"></span></p>",
    "correct_choice_id": 40762,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 10166,
    "choices": [
      {
        "id": 40630,
        "text": "<p><span style=\"font-size:12.0pt;\">2,00,000 IU immediately, followed by same dose after 24 hours</span></p>"
      },
      {
        "id": 40631,
        "text": "<p><span style=\"font-size:12.0pt;\">1,00,000 IU immediately, followed by the same dose after 1 week</span></p>"
      },
      {
        "id": 40632,
        "text": "<p><span style=\"font-size:12.0pt;\">1,00,000 IU immediately, followed by the same dose after 24 hours and after a week</span></p>"
      },
      {
        "id": 40633,
        "text": "<p><span style=\"font-size:12.0pt;\">2,00,000 IU immediately, followed by the same dose 24 hours later and after 2 weeks</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the recommended amount of vitamin A dosage for a 2-year-old child diagnosed with keratomalacia? (NEET PG 2019)</span></p>",
    "unique_key": "Q9485008",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175024,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>2,00,000 IU immediately, followed by the same dose 24 hours later and after 2 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The recommended treatment for a 2-year-old child diagnosed with keratomalacia involves high-dose vitamin A supplementation to rapidly replenish depleted stores and prevent further ocular damage. The specific dosage regimen is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">2,00,000 IU of vitamin A administered immediately.</span></li><li><span style=\"font-size:12.0pt;\">2,00,000 IU administered again 24 hours later.</span></li><li><span style=\"font-size:12.0pt;\">2,00,000 IU administered again after 2 weeks.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This regimen is designed to quickly correct vitamin A deficiency and provide sustained support to prevent recurrence and promote healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The suggested vitamin A dose for a 2-year-old child diagnosed with keratomalacia is 200,000 IU, administered promptly, then repeated with the same age-appropriate amount after 24 hours and again after a span of 2 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dosage of Vitamin A as per age: -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">&lt;6 months \u2013 50,000 IU orally</span></li><li><span style=\"font-size:12.0pt;\">6-12 months \u2013 1,00,000 IU orally</span></li><li><span style=\"font-size:12.0pt;\">above 12 months \u2013 2,00,000 IU orally</span></li></ul>",
    "correct_choice_id": 40633,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "OlderNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 11072,
    "choices": [
      {
        "id": 44254,
        "text": "<p><span style=\"font-size:12.0pt;\">If 1, 2, and 3 are correct</span></p>"
      },
      {
        "id": 44255,
        "text": "<p><span style=\"font-size:12.0pt;\">If 1 and 3 are correct</span></p>"
      },
      {
        "id": 44256,
        "text": "<p><span style=\"font-size:12.0pt;\">If 2 and 4 are correct</span></p>"
      },
      {
        "id": 44257,
        "text": "<p><span style=\"font-size:12.0pt;\">If all (1,2,3 &amp; 4) are correct</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A team of researchers is conducting investigations to evaluate the impact of interventions targeting a specific disease. Two independent studies, labeled as A and B, are analyzed. Study A utilized an intervention denoted as \"X\", and Study B utilized an intervention denoted as \"Y\". Both studies incorporate control groups. The calculated p-values for studies A and B, with 95% confidence intervals, were found to be 0.02 and 0.001, respectively.&nbsp; Based on this information, which of the following conclusions is most appropriate? (AIIMS MAY 2019)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Study B is more precise than study A and intervention Y is more significant compared to Intervention X.</span></li><li><span style=\"font-size:12.0pt;\">Study A is more precise than study B and intervention X is more significant compared to Intervention Y.</span></li><li><span style=\"font-size:12.0pt;\">Both X and Y show a significant variation, but Study B is more significant than Study A.</span></li><li><span style=\"font-size:12.0pt;\">Both study A and B show a significant variation and both interventions have similar statistical significance.</span></li></ol>",
    "unique_key": "Q3138505",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175029,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) If 1 and 3 are correct</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Statements 1 and 3 are accurate. The p-value for study A involving intervention X within a 95% confidence interval stands at 0.02.</span></li><li><span style=\"font-size:12.0pt;\">In the case of study B, employing intervention Y within the same confidence interval, the p-value is 0.001.</span></li><li><span style=\"font-size:12.0pt;\">Both studies' probability (p) values fall below the 0.05 threshold (level of significance - \u03b1), leading to the conclusion that both studies A and B hold significance and thus warrant the rejection of the null hypothesis.</span></li><li><span style=\"font-size:12.0pt;\">Nevertheless, study B exhibits a p-value lower than that of study A, implying that the precision and significance of study B, involving intervention Y, surpass those of study A with intervention X.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option 2:</strong> This is incorrect as it mistakenly asserts that Study A, which had a higher p-value, would be more precise and that intervention X would be more significant than intervention Y. This is opposite to what the p-values suggest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option 4:</strong> Also incorrect because it suggests that both interventions have similar statistical significance, which contradicts the considerable difference in their p-values. A lower p-value in Study B indicates a stronger statistical significance compared to Study A.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In interpreting clinical study results, a lower p-value indicates stronger evidence against the null hypothesis and typically points to a more significant intervention effect.</span></li><li><span style=\"font-size:12.0pt;\">In this scenario, Study B's intervention (Y) is statistically more significant than Study A's intervention (X), indicating a potentially more effective or impactful intervention.</span></li></ul>",
    "correct_choice_id": 44255,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 44286,
    "choices": [
      {
        "id": 176795,
        "text": "<p><span style=\"font-size:12.0pt;\">Air temperature</span></p>"
      },
      {
        "id": 176796,
        "text": "<p><span style=\"font-size:12.0pt;\">Air velocity</span></p>"
      },
      {
        "id": 176797,
        "text": "<p><span style=\"font-size:12.0pt;\">Air humidity</span></p>"
      },
      {
        "id": 176798,
        "text": "<p><span style=\"font-size:12.0pt;\">Cooling air</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The instrument given below is used to measure: (FMGE JANUARY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/20/screenshot-2024-05-20-112204.JPG\" alt=\"\" width=\"400\" height=\"300\"></span></p>",
    "unique_key": "Q7898728",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175059,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Air humidity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a <strong>sling psychrometer</strong>, which is an instrument used to measure the <strong>water content, moisture content, or air humidity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A sling psychrometer consists of two thermometers, one of which has a wet bulb (covered in a wet cloth) and the other a dry bulb. By comparing the temperatures of the wet and dry bulbs, the relative humidity can be determined using a psychrometric chart or calculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>A. Air temperature:</strong> While the sling psychrometer does measure air temperature using the dry bulb thermometer, its primary purpose is to measure humidity by comparing the dry and wet bulb temperatures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>B. Air velocity:</strong> The sling psychrometer is not designed to measure air velocity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>D. Cooling air:</strong> In the past, the Kata thermometer was used to measure the cooling power of air, but it is now primarily used to assess low air velocity. The sling psychrometer is not designed to measure the cooling effect of air.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The sling psychrometer is an instrument used to measure air humidity by comparing the temperatures of a wet bulb and a dry bulb thermometer.</span></p>",
    "correct_choice_id": 176797,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "FMGE",
      "ImageBased",
      "InstrumentsBased"
    ]
  },
  {
    "id": 11109,
    "choices": [
      {
        "id": 44402,
        "text": "<p><span style=\"font-size:12.0pt;\">For the prevention of typhoid most important step is immunization</span></p>"
      },
      {
        "id": 44403,
        "text": "<p><span style=\"font-size:12.0pt;\">Proper disposal of feces, safe water supply, and personal hygiene is more important than immunization</span></p>"
      },
      {
        "id": 44404,
        "text": "<p><span style=\"font-size:12.0pt;\">Resistance to drugs in typhoid is less severe than that of TB</span></p>"
      },
      {
        "id": 44405,
        "text": "<p><span style=\"font-size:12.0pt;\">Person to person transmission is present in 10% of cases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During a community health education session, an MBBS student is discussing the prevention of Typhoid Fever. Which of the following statements best captures the primary measures for preventing the transmission of Typhoid in the community? (INICET MAY 2022)</span></p>",
    "unique_key": "Q3160877",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175042,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Proper disposal of feces, safe water supply, personal hygiene is more important than immunization</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The control of typhoid fever must be through improved sanitation and domestic/ personal hygiene.</span></li><li><span style=\"font-size:12.0pt;\">Complementary approaches to prevention include immunization which is the only specific preventive measure likely to provide highest benefit for the money spent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. For the prevention of typhoid most important step is immunization:</strong> Incorrect. While important, immunization is not the most critical step compared to improving sanitation and hygiene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Resistance to drugs in typhoid is less severe than that of TB:</strong> Incorrect. This statement is unrelated to primary prevention measures for typhoid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Person to person transmission is present in 10% of cases:</strong> Incorrect. Person-to-person transmission is not a significant mode of transmission for typhoid compared to the ingestion of contaminated food or water.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The primary measures for preventing the transmission of Typhoid Fever in the community include proper disposal of feces, a safe water supply, and personal hygiene.</span></li><li><span style=\"font-size:12.0pt;\">These measures are more important than immunization for controlling the spread of the disease.</span></li></ul>",
    "correct_choice_id": 44403,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 10137,
    "choices": [
      {
        "id": 40514,
        "text": "<p><span style=\"font-size:12.0pt;\">Article 11</span></p>"
      },
      {
        "id": 40515,
        "text": "<p><span style=\"font-size:12.0pt;\">Article 21</span></p>"
      },
      {
        "id": 40516,
        "text": "<p><span style=\"font-size:12.0pt;\">Article 23</span></p>"
      },
      {
        "id": 40517,
        "text": "<p><span style=\"font-size:12.0pt;\">Article 25</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which article in the Indian Constitution grants the Right to Life to the individuals of India? (NEET PG 2018)</span></p>",
    "unique_key": "Q4079209",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175012,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Article 21</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Article 21 of the Indian Constitution guarantees the Right to Life and personal liberty to all its citizens. This article is pivotal as it ensures that no person is deprived of their life or personal liberty except according to the procedure established by law. This right is comprehensive, covering a range of aspects that ensure not just mere survival but a life with dignity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Article 11:&nbsp;</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">defines the right of the parliament to regulate the right of citizenship by law.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Article 23:&nbsp;</strong> defines the prohibition of traffic in human beings and forced labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Article 25:&nbsp;</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">defines the freedom of conscience and free profession, practice, and propagation of religion. While it pertains to personal liberties, it specifically addresses religious freedoms and not the general Right to Life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Article 21 of the Indian Constitution is critical as it enshrines the Right to Life and personal liberty, ensuring that every individual's life and personal freedoms are protected under the law.</span></p>",
    "correct_choice_id": 40515,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 11135,
    "choices": [
      {
        "id": 44506,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cytotoxic waste</span></p>"
      },
      {
        "id": 44507,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Biomedical waste</span></p>"
      },
      {
        "id": 44508,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Radiation hazard</span></p>"
      },
      {
        "id": 44509,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Biohazard</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Based on the emblem as shown below, which of the following best describes the warning it signifies? </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2018)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip37.jpg\" alt=\"\" width=\"300\" height=\"302\"></p>",
    "unique_key": "Q7675897",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175060,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Radiation hazard</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>INTERNATIONAL RADIATION SYMBOL (TREFOIL)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Central circle of radius R, an internal radius of 1.5R and an external radius of 5R for the blades, which are separated from each other by 60\u00b0</span></li><li><span style=\"color:black;font-size:12.0pt;\">Trefoil is black in the international version</span></li><li><span style=\"color:black;font-size:12.0pt;\">Commonly referred to as a Radioactivity warning sign, but it is actually a warning sign of ionizing radiation</span></li><li><span style=\"color:black;font-size:12.0pt;\">Includes X-ray apparatus, medical beam cannons and particle accelerators.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cytotoxic waste:</strong> This waste includes materials that are toxic to cells, such as chemotherapy waste, but uses a different symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Biomedical waste:</strong> This refers to waste generated from medical procedures, often marked with a biohazard symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Biohazard:</strong> Indicates the presence of biological substances that pose a threat to human health, marked with a different symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip38.jpg\" alt=\"\" width=\"700\" height=\"243\"></span></p>",
    "correct_choice_id": 44508,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 10231,
    "choices": [
      {
        "id": 40890,
        "text": "<p><span style=\"font-size:12.0pt;\">Moderately polluted</span></p>"
      },
      {
        "id": 40891,
        "text": "<p><span style=\"font-size:12.0pt;\">Poor</span></p>"
      },
      {
        "id": 40892,
        "text": "<p><span style=\"font-size:12.0pt;\">Very poor</span></p>"
      },
      {
        "id": 40893,
        "text": "<p><span style=\"font-size:12.0pt;\">Severe</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Below is the air pollution index chart for four consecutive days at the Delhi station. What is the categorization of the air quality index for November 23<sup>rd</sup>? (NEET PG 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-130538.png\" alt=\"\" width=\"1000\" height=\"259\"></p>",
    "unique_key": "Q6396762",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175054,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Severe</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Based on the information provided in the query, the air quality index on November 23rd is measured at 407, falling under the severe category.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>AIR QUALITY INDEX (AQI)</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A tool used for effective communication of air quality status on a scale that is easily comprehensible. Complex air quality data of various pollutants are compiled to give a single score (index value), nomenclature and color that determines the air pollution of that particular location.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eight pollutants are taken into consideration to calculate the AQI -</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">PM10 (Airborne particulate matter with a diameter of 10 microns or less)</span></li><li><span style=\"font-size:12.0pt;\">PM2.5 (Airborne particulate matter with a diameter of 2.5 microns or less)</span></li><li><span style=\"font-size:12.0pt;\">NO2 (Nitrogen dioxide)</span></li><li><span style=\"font-size:12.0pt;\">SO2 (Sulfur dioxide)</span></li><li><span style=\"font-size:12.0pt;\">CO (Carbon monoxide)</span></li><li><span style=\"font-size:12.0pt;\">03 (Ozone/Trioxygen)</span></li><li><span style=\"font-size:12.0pt;\">NH3 (Ammonia)</span></li><li><span style=\"font-size:12.0pt;\">Pb (Lead)</span></li></ol><p style=\"margin-left:17px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">AQl categories and the range are as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-130725.png\" alt=\"\" width=\"1000\" height=\"583\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-130755.png\" alt=\"\" width=\"400\" height=\"299\"></p>",
    "correct_choice_id": 40893,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11124,
    "choices": [
      {
        "id": 44462,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence increases and prevalence reduces</span></p>"
      },
      {
        "id": 44463,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence remains the same</span></p>"
      },
      {
        "id": 44464,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence remains the same and prevalence increases</span></p>"
      },
      {
        "id": 44465,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A new combined treatment regimen of chemotherapy and immunotherapy has significantly increased survival in patients with metastatic melanoma. If the number of new cases remains consistent, but patients live longer, which epidemiological impact would be observed? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q4596918",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175051,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Incidence remains the same and prevalence increases</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Due to the new drug combination, patient survival rates have risen, resulting in a situation where the incidence remains unchanged while prevalence sees an increase.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>PREVALENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Total current (Old + New) cases in a given population over.</span></li><li><span style=\"font-size:12.0pt;\">Prevalence = Incidence \u00d7 Mean duration of disease [P = I \u00d7 d]</span></li><li><span style=\"font-size:12.0pt;\">Prevalence describes the balance between incidence, mortality and recovery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>INCIDENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Number of new cases occurring in a defined population over a specified period of time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Since New cases will keep on occurring at the same rate, Incidence will remain same. Duration will increase (as survival increases). So, overall Prevalence will increase.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">When patient survival increases due to a new treatment, the incidence of the disease remains the same, but the prevalence increases due to longer survival duration.</span></li></ul>",
    "correct_choice_id": 44464,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10472,
    "choices": [
      {
        "id": 41854,
        "text": "<p><span style=\"font-size:12.0pt;\">Increased old age dependency ratio</span></p>"
      },
      {
        "id": 41855,
        "text": "<p><span style=\"font-size:12.0pt;\">Decreased old age dependency ratio</span></p>"
      },
      {
        "id": 41856,
        "text": "<p><span style=\"font-size:12.0pt;\">Increased young age dependency ratio</span></p>"
      },
      {
        "id": 41857,
        "text": "<p><span style=\"font-size:12.0pt;\">Decreased young age dependency ratio</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following scenarios would contribute the most to the demographic burden in a country? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q3280244",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175045,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Increased old age dependency ratio</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Demographic burden is represented by age dependency ratio. Increase in old age dependency ratio majorly contribute to demographic burden.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Demographic bonus </strong>is a condition in which the productive age population is more than the non-productive population. When we have a higher number of economically productive population, it is called as a demographic bonus. It is achieved when we can see a decline in the dependency ratio.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An increased old age dependency ratio contributes significantly to the demographic burden in a country with a growing elderly population.</span></p>",
    "correct_choice_id": 41854,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10476,
    "choices": [
      {
        "id": 41870,
        "text": "<p><span style=\"font-size:12.0pt;\">Mean</span></p>"
      },
      {
        "id": 41871,
        "text": "<p><span style=\"font-size:12.0pt;\">Median</span></p>"
      },
      {
        "id": 41872,
        "text": "<p><span style=\"font-size:12.0pt;\">Mode</span></p>"
      },
      {
        "id": 41873,
        "text": "<p><span style=\"font-size:12.0pt;\">Mean deviation</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In a health survey from a diverse district near Pune, the data shows a wide range of values due to different urban and rural populations. Which measure of central tendency is most appropriate for summarizing this data given its variability? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q9964709",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175049,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Median</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The median is the most appropriate measure of central tendency for this data because it is not affected by extreme values or outliers. In a dataset with a wide range of values, such as one from a diverse district, the median provides a better summary of the central value by focusing on the middle point, thereby mitigating the impact of extremes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mean:</strong> The mean is the average of all values and can be skewed by extreme values, making it less representative in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mode:</strong> The mode is the most frequently occurring value but may not reflect the central tendency in a dataset with a wide range of values.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mean deviation:</strong> Mean deviation measures dispersion, not central tendency, and thus does not summarize the central value effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The median is the best measure of central tendency for datasets with a wide range of values or outliers, as it is unaffected by extremes.</span></p>",
    "correct_choice_id": 41871,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 11037,
    "choices": [
      {
        "id": 44114,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Only vial 1 can be used</span></p>"
      },
      {
        "id": 44115,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vials 1 and 2 can be used</span></p>"
      },
      {
        "id": 44116,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vials 1, 2, and 3 can be used</span></p>"
      },
      {
        "id": 44117,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">All vials can be used</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Sunita, a medical officer in a rural health clinic, is tasked with ensuring the potency and safety of vaccines. She comes across several vaccine vials, each with a Vaccine Vial Monitor (VVM) attached. The VVMs change color to indicate the cumulative exposure of the vaccine to heat, thus helping in determining the viability of the vaccine. She notices varying degrees of color changes across these VVMs. Given this scenario, which of the following choices correctly identifies which vaccine vials, based on the observed VVM color changes, should be considered safe for use? (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-113411.png\" alt=\"\" width=\"200\" height=\"1073\"></p>",
    "unique_key": "Q5219256",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175014,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans.&nbsp;B) Vials 1 and 2 can be used</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Based on the image provided, it's evident that only vials 1 and 2 are suitable for use because the inner squares of these vials color lighter than the outer circles.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain.</span></li><li><span style=\"color:black;font-size:12.0pt;\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></li><li><span style=\"color:black;font-size:12.0pt;\">A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Expiry date can\u2019t be determined by VVM and has no relation to extend the expiry date.</span></li><li><span style=\"color:black;font-size:12.0pt;\">If the square and the circle are the same in colour, then the vaccine should be discarded.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture2.jpg\" alt=\"\" width=\"700\" height=\"372\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture1_YnCLGDy.jpg\" alt=\"\" width=\"800\" height=\"580\"></span></p>",
    "correct_choice_id": 44115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 57572,
    "choices": [
      {
        "id": 229657,
        "text": "<p><span style=\"font-size:12.0pt;\">Air pollution</span></p>"
      },
      {
        "id": 229658,
        "text": "<p><span style=\"font-size:12.0pt;\">Air humidity</span></p>"
      },
      {
        "id": 229659,
        "text": "<p><span style=\"font-size:12.0pt;\">Cooling power of air</span></p>"
      },
      {
        "id": 229660,
        "text": "<p><span style=\"font-size:12.0pt;\">Low air velocity</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The given instrument is used for: (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173258.jpg\" alt=\"\" width=\"400\" height=\"104\"></span></p>",
    "unique_key": "Q8809586",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175041,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp; D) Low air velocity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The instrument shown in the image is a Kata thermometer. The Kata thermometer was traditionally used to measure the cooling power of air. This measurement is based on how quickly the thermometer cools down when exposed to moving air, which directly correlates to the cooling effect of the air. However, its modern application is primarily focused on assessing low air velocity. It measures the rate of heat loss in still air, helping to determine the movement and speed of low-velocity air in environments such as controlled climates or specific laboratory conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Air pollution</strong>: The Kata thermometer is not used to measure air pollution. Air pollution measurement typically involves devices that can detect particulate matter or specific pollutants, such as gas analyzers or particle counters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Air humidity</strong>: Measuring air humidity is generally done using hygrometer. Hygrometers determine the amount of moisture in the air, which is unrelated to the cooling effect or air velocity measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cooling power of air</strong>: Although historically correct, this option is no longer the primary use of the Kata thermometer. The instrument was used in the past for this purpose, but it has evolved to mainly assess low air velocity, making this answer outdated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Kata thermometer is primarily used today to assess low air velocity.</span></p>",
    "correct_choice_id": 229660,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10855,
    "choices": [
      {
        "id": 43386,
        "text": "<p><span style=\"font-size:12.0pt;\">Chlorine</span></p>"
      },
      {
        "id": 43387,
        "text": "<p><span style=\"font-size:12.0pt;\">Fluorine</span></p>"
      },
      {
        "id": 43388,
        "text": "<p><span style=\"font-size:12.0pt;\">Iodine</span></p>"
      },
      {
        "id": 43389,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 5-year-old boy has developed white patches on his anterior incisors, which have recently turned brown. His mother is concerned about the cause. Which element is most likely responsible for this discoloration? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q2995330",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175044,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Fluorine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dental fluorosis occurs when excess fluoride is ingested during first 7 years of life (years of tooth calcification). It occurs at levels above 1.5 mg/litre intake. It is characterized by \u2019Mottling\u2019, which is best seen on incisors of upper jaw.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Definition of Suspect case of Dental Fluorosis (in children):</strong> Any case with a history of residing in an endemic area along with one or both of the followings:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Chalky white teeth/white spots on the white enamel surface</span></li><li><span style=\"font-size:12.0pt;\">Transverse yellow, brown/black bands or spots on the enamel surface</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-181749.jpg\" alt=\"\" width=\"700\" height=\"255\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ideally in water there should be 0.5 to 0.8 mg/l of fluorine (India). The major source of fluorine in human is Drinking water.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chlorine:</strong> Chlorine is used for water disinfection and is not associated with dental discoloration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iodine:</strong> Iodine deficiency can cause goiter and other thyroid-related issues but not dental discoloration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Iron: </strong>Excessive iron can cause dark stains on teeth but does not cause the white to brown transition seen in dental fluorosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dental fluorosis is caused by the ingestion of excess fluoride during the early years of life, leading to characteristic tooth discoloration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluorine is a double edged sword.&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Dental Fluorosis occurs when Fluorine level is &gt; 0.8mg/l in water. In that case, the water should be defluoridated using Nalgonda technique.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">If the level of fluorine is &lt; 0.5mg/l, then the fluorine deficiency will lead to Dental Caries. In that case, fluorine supplementation should be done.</span><ul><li><span style=\"font-size:12.0pt;\">Level &gt; 1.5 ppm: Dental fluorosis (mottling)</span></li><li><span style=\"font-size:12.0pt;\">Level 3.0 - 6.0 ppm: Skeletal fluorosis</span></li><li><span style=\"font-size:12.0pt;\">Level &gt; 10.0 ppm: Crippling fluorosis</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluorosis endemic area: Habitation/village/town having fluoride level &gt; 1.5 ppm in drinking water. Villages classification based on the level of fluoride content:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-181922.jpg\" alt=\"\" width=\"700\" height=\"581\"></span></p>",
    "correct_choice_id": 43387,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 20349,
    "choices": [
      {
        "id": 81357,
        "text": "<p><span style=\"font-size:12.0pt;\">Green</span></p>"
      },
      {
        "id": 81358,
        "text": "<p><span style=\"font-size:12.0pt;\">Red</span></p>"
      },
      {
        "id": 81359,
        "text": "<p><span style=\"font-size:12.0pt;\">Grey</span></p>"
      },
      {
        "id": 81360,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 22-year-old female comes to the STI clinic with minimal vaginal discharge. On speculum examination, erosions are seen on the cervix. Which of the following kit should be given to this patient? (NEET PG 2023)</span></p>",
    "unique_key": "Q1668333",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175058,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Grey</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with erosions on the cervix, which is indicative of cervicitis. According to the syndromic management guidelines for sexually transmitted infections (STIs), cervicitis is treated with the Grey Kit (Kit 1).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>STI color coded kits:&nbsp;</strong></span><br>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-095220.png\" alt=\"\" width=\"1000\" height=\"349\"></p>",
    "correct_choice_id": 81359,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 11151,
    "choices": [
      {
        "id": 44570,
        "text": "<p><span style=\"font-size:12.0pt;\">Direct observation with a structured checklist</span></p>"
      },
      {
        "id": 44571,
        "text": "<p><span style=\"font-size:12.0pt;\">Closed circuit camera surveillance</span></p>"
      },
      {
        "id": 44572,
        "text": "<p><span style=\"font-size:12.0pt;\">In-depth interview with the patient</span></p>"
      },
      {
        "id": 44573,
        "text": "<p><span style=\"font-size:12.0pt;\">In-depth interview with the healthcare provider</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A newly established hospital aims to maintain the highest standards of care and ensure patient safety by standardizing injection practices among health workers. They seek a reliable method for real-time assessment of these practices. Which of the following would be the most appropriate method to monitor the injection practices of health workers? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q6037817",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175007,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Direct observation with a structured checklist</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most effective approach for assessing the injection practices of healthcare workers is through direct observation using a structured checklist.</span></li><li><span style=\"font-size:12.0pt;\">This method allows for real-time, accurate assessment of adherence to aseptic techniques and best practices.</span></li><li><span style=\"font-size:12.0pt;\">A structured checklist ensures all critical steps are monitored and recorded systematically.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Closed circuit camera surveillance:&nbsp;</strong>While it may offer some insights, it lacks the detail and real-time assessment provided by direct observation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. In-depth interview with the patient:&nbsp;</strong>Patients may not have the expertise to accurately comment on the technical aspects of injection practices.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. In-depth interview with the healthcare provider:&nbsp;</strong>This relies on self-reporting, which may be biased and not always accurate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most effective approach for assessing the injection practices of healthcare workers is through direct observation using a structured checklist.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-104556.png\" alt=\"\" width=\"1000\" height=\"874\"></p>",
    "correct_choice_id": 44570,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 55483,
    "choices": [
      {
        "id": 221389,
        "text": "<p><span style=\"font-size:12.0pt;\">Louse</span></p>"
      },
      {
        "id": 221390,
        "text": "<p><span style=\"font-size:12.0pt;\">Mites</span></p>"
      },
      {
        "id": 221391,
        "text": "<p><span style=\"font-size:12.0pt;\">Flea</span></p>"
      },
      {
        "id": 221392,
        "text": "<p><span style=\"font-size:12.0pt;\">Ticks</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which vector is responsible for transmitting Rickettsia Tsutsugamushi? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q3479499",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175027,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Mites.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rickettsia Tsutsugamushi is the causative agent of scrub typhus, a type of rickettsial disease. The primary vector responsible for transmitting Rickettsia Tsutsugamushi is the trombiculid mite, commonly known as a chigger. These mites are parasitic larvae that bite humans and other animals, transmitting the bacteria through their saliva during feeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Scrub typhus is prevalent in areas with dense scrub vegetation, hence the name. Rodents often serve as the reservoir hosts for the bacteria, maintaining the infection cycle in nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. &nbsp;Louse:&nbsp;</strong>Lice are vectors for other rickettsial diseases, such as epidemic typhus (Rickettsia prowazekii), but not for scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Flea:&nbsp;</strong>Fleas are vectors for diseases like murine typhus (Rickettsia typhi) but are not involved in the transmission of scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ticks:&nbsp;</strong>Ticks transmit various rickettsial diseases, including Rocky Mountain spotted fever (Rickettsia rickettsii), but not scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Scrub typhus, caused by Rickettsia Tsutsugamushi, is transmitted by the trombiculid mite, making mites the vector responsible for this disease.</span></p>",
    "correct_choice_id": 221390,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 11036,
    "choices": [
      {
        "id": 44110,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Alpha error</span></p>"
      },
      {
        "id": 44111,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Beta error</span></p>"
      },
      {
        "id": 44112,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1-\u03b1</span></p>"
      },
      {
        "id": 44113,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1-\u03b2</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Sharma was enthusiastically reviewing the results of a randomized controlled trial (RCT) that aimed to compare the therapeutic benefits of Drug A and Drug B. To her surprise, the data suggested a statistically significant difference between the two medications, indicated by a p-value of &lt;0.005. However, after a comprehensive review and collaboration with other experts, it was established that in real-world settings, both drugs had essentially equivalent therapeutic outcomes. This error in interpretation, where a difference was falsely identified when none existed in reality, is best described by which of the following statistical terms? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q9569090",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175013,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Alpha error</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">In the given scenario, null hypothesis (H<sub>0</sub>) can be that the two drugs being the same in effectiveness is true in reality.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The alternative hypothesis will be that both drugs are different.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Since P-value was found to be &lt; 0.005, means that data is statistically significant and thus, null hypothesis is rejected.</span></li><li><span style=\"color:black;font-size:12.0pt;\">But it is already established that the null hypothesis is true and now if we accept the alternative hypothesis even though it is false, this will be a type I error or alpha error.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hypothesis (H): Is an assumption about the status of a phenomenon</span></li><li><span style=\"color:black;font-size:12.0pt;\">Null Hypothesis (H<sub>0</sub>): In Biostatistics, when we have to prove a particular hypothesis about difference between 2 regimens, we make Null Hypothesis (For examples, If we have to prove that new treatment is better than older treatment, H<sub>0</sub> = new treatment is not better than older treatment).</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Statistical errors:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114514.jpg\" alt=\"\" width=\"800\" height=\"183\"></strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Type I Error (Alpha Error):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Null hypothesis is true but rejected</span></li><li><span style=\"color:black;font-size:12.0pt;\">Probability of Type I error is given by \u2018P \u2013 value\u2019 (probability of declaring a significant difference when actually it is not present)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Significance (a) level: is the maximum tolerable probability of Type I error</span></li><li><span style=\"color:black;font-size:12.0pt;\">Alpha is fixed in advance: P \u2013 value calculated can be less than, equal to or greater than alpha (a)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Keep Type I error to be minimum (P &lt; a): Then results are declared statistically significant</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Type II Error (Beta Error):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Null hypothesis is false but not rejected (or accepted)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Probability of Type II error is given by beta (b) (probability of declaring no significant difference when actually it is present)</span></li></ul>",
    "correct_choice_id": 44110,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 24755,
    "choices": [
      {
        "id": 98981,
        "text": "<p><span style=\"font-size:12.0pt;\">Cohort study</span></p>"
      },
      {
        "id": 98982,
        "text": "<p><span style=\"font-size:12.0pt;\">Retrospective cohort</span></p>"
      },
      {
        "id": 98983,
        "text": "<p><span style=\"font-size:12.0pt;\">Nested case control</span></p>"
      },
      {
        "id": 98984,
        "text": "<p><span style=\"font-size:12.0pt;\">Cross control cohort</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A study involved 30,000 women who were monitored for a period of 10 years to track the occurrence of breast cancer. Among them, 1200 women developed cancer and were subsequently given a questionnaire to evaluate potential risk factors. In parallel, 2000 women from the same study served as controls and were also subjected to the questionnaire. What is the name of this type of study? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
    "unique_key": "Q3580362",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175022,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Nested case control</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Given scenario dictates that a population was monitored for development of breast cancer.</span></li><li><span style=\"font-size:12.0pt;\">Out of which, 1200 women developed breast cancer and a small subgroup was taken as control.</span></li><li><span style=\"font-size:12.0pt;\">This study structure points to Nested case control study.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256120_page_4.jpg\" alt=\"\" width=\"700\" height=\"546\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cohort study:</strong> Cohort study</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">involves selecting Exposed and non-exposed groups then follow them for development of outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Retrospective cohort:</strong> In Retrospective cohort, the outcomes have already occurred before the study begins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cross control cohort:</strong> Cross control cohort is not a study design.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A nested case-control study involves identifying cases and controls from an existing cohort that is being followed over time, making it a cost-effective way to study the associations between exposures and outcomes.</span></li></ul>",
    "correct_choice_id": 98983,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10856,
    "choices": [
      {
        "id": 43390,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcium</span></p>"
      },
      {
        "id": 43391,
        "text": "<p><span style=\"font-size:12.0pt;\">Selenium</span></p>"
      },
      {
        "id": 43392,
        "text": "<p><span style=\"font-size:12.0pt;\">Iodine</span></p>"
      },
      {
        "id": 43393,
        "text": "<p><span style=\"font-size:12.0pt;\">Copper</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following listed minerals is NOT typically classified as a trace nutrient? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q1614716",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175046,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Calcium</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Carbohydrates, fats and proteins are Macronutrients (Proximate principles). &nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Micronutrients include Calcium, Phosphorus, Magnesium, Sodium, Potassium, Iron, Zinc and Vitamins.</span></li><li><span style=\"font-size:12.0pt;\">Trace nutrients include iron, manganese, copper, iodine, zinc, cobalt, fluoride and selenium.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Calcium is a macronutrient, needed in larger amounts. Selenium, iodine, and copper are trace nutrients, required in smaller quantities.</span></p>",
    "correct_choice_id": 43390,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 11095,
    "choices": [
      {
        "id": 44346,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
      },
      {
        "id": 44347,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
      },
      {
        "id": 44348,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
      },
      {
        "id": 44349,
        "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman comes to your clinic for her postpartum checkup. She mentions that she has been exclusively breastfeeding her newborn and is concerned about meeting her own nutritional needs in order to ensure the best for her baby. She asks you about specific nutrient supplementation she might need during this period of lactation. Compared to her pregnancy, which nutrient would you recommend she should pay particular attention to increasing? (INICET MAY 2021)</span></p>",
    "unique_key": "Q6115894",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175037,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin A</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The requirement for Vitamin A increases during lactation more than during pregnancy.</span></li><li><span style=\"font-size:12.0pt;\">Vitamin A is essential for ensuring the quality of breast milk, which is the sole source of nutrition for a newborn.</span></li><li><span style=\"font-size:12.0pt;\">It plays a critical role in the development of the baby\u2019s immune system and visual function.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>According to the latest Nutritional Guidelines,</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Requirement in Pregnancy &gt; Lactation <strong>\u2192</strong> Proteins; Zinc; Folic Acid; Iron</span></li><li><span style=\"font-size:12.0pt;\">Requirement in Lactation &gt; Pregnancy <strong>\u2192&nbsp;</strong>Vitamin A; Iodine; Vitamin C; Carbohydrates, Calcium</span></li><li><span style=\"font-size:12.0pt;\">Requirement in Pregnancy = Lactation <strong>\u2192</strong> Vitamin D; Calcium</span></li></ul>",
    "correct_choice_id": 44346,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10255,
    "choices": [
      {
        "id": 40986,
        "text": "<p><span style=\"font-size:12.0pt;\">Green tea increases the risk of diabetes</span></p>"
      },
      {
        "id": 40987,
        "text": "<p><span style=\"font-size:12.0pt;\">Green tea decreases the risk of diabetes</span></p>"
      },
      {
        "id": 40988,
        "text": "<p><span style=\"font-size:12.0pt;\">Data insufficient to establish causal association</span></p>"
      },
      {
        "id": 40989,
        "text": "<p><span style=\"font-size:12.0pt;\">The value (0.84) tends to be close to 1, hence there is no effect</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A cohort study was carried out involving individuals who consumed green tea and those who did not, aiming to examine its impact on diabetes mellitus. The calculated risk ratio stood at 0.84. Which of the subsequent statements is accurate?&nbsp;</span>(NEET PG 2022)</p>",
    "unique_key": "Q4665160",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175008,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Green tea decreases the risk of diabetes</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Green tea consumption decreases the risk of DM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Relative risk &lt;1 implies negative/inverse association, i.e., risk factor is rather protective for the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk ratio of 0.84 indicates that the incidence of diabetes mellitus is lower in the group of drinkers of green tea compared to the group of non-drinkers. Therefore, it can be concluded that green tea decreases the risk of diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Relative risk (RR) = Incidence among exposed/Incidence among non-exposed</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-103632.png\" alt=\"\" width=\"1000\" height=\"192\"></strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Note - Strength of association in a cohort study is evaluated by:\u2013 Relative risk, Attributable risk (AR), Population attributable risk (PAR)</strong></span></p>",
    "correct_choice_id": 40987,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11190,
    "choices": [
      {
        "id": 44726,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 44727,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
      },
      {
        "id": 44728,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
      },
      {
        "id": 44729,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man has been diagnosed with tuberculosis. As part of his treatment plan, he is prescribed a combination of antitubercular drugs. While counseling him on the drug regimen, you explain the mechanisms of action of each drug. Which of the following combinations of statements accurately describe the mechanisms of some of the drugs used in treating tuberculosis? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Isoniazid inhibits mycolic acid synthesis</span></li><li><span style=\"font-size:12.0pt;\">Pyrazinamide is an enzyme inducer</span></li><li><span style=\"font-size:12.0pt;\">Rifampicin is used only in the treatment of tuberculosis</span></li><li><span style=\"font-size:12.0pt;\">Bedaquiline inhibits ATP synthase</span></li></ol>",
    "unique_key": "Q6733346",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175025,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. lsoniazid -&nbsp;</strong>INH is activated by catalase peroxidase (formed by Kat G) enzyme of mycobacteria. It acts by inhibiting the formation of mycolic acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Bedaquiline -</strong> Act by inhibiting ATP synthase enzyme, can result in QT prolongation</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Pyrazinamide -&nbsp;</strong>Possess the best sterilizing activity (can kill slow growing bacteria) and makes the medium sterile. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. It is not an enzyme inducer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Rifampicin -&nbsp;</strong>Act by inhibiting RNA polymerase of mycobacteria by binding to its \u03b2-subunit. It thus inhibits transcription.<strong> </strong>Uses of Rifampicin are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tuberculosis</span></li><li><span style=\"font-size:12.0pt;\">Leprosy</span></li><li><span style=\"font-size:12.0pt;\">DOC for Brucella (doxycycline + rifampicin)</span></li><li><span style=\"font-size:12.0pt;\">Effective against Gram positive bacteria (including MRSA)</span></li><li><span style=\"font-size:12.0pt;\">Effective against Gram negative bacteria (including Pseudomonas)</span></li><li><span style=\"font-size:12.0pt;\">It was used for prophylaxis of meningococcus meningitis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Isoniazid inhibits mycolic acid synthesis.</span></li><li><span style=\"font-size:12.0pt;\">Bedaquiline inhibits ATP synthase enzyme.</span></li><li><span style=\"font-size:12.0pt;\">Pyrazinamide inhibits trans-translation</span></li><li><span style=\"font-size:12.0pt;\">Rifampicin inhibit RNA polymerase</span></li></ul>",
    "correct_choice_id": 44729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 57573,
    "choices": [
      {
        "id": 229661,
        "text": "<p><span style=\"font-size:12.0pt;\">1 only</span></p>"
      },
      {
        "id": 229662,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2 only</span></p>"
      },
      {
        "id": 229663,
        "text": "<p><span style=\"font-size:12.0pt;\">All three</span></p>"
      },
      {
        "id": 229664,
        "text": "<p><span style=\"font-size:12.0pt;\">2 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">HDI is calculated by using ?&nbsp; (NEET PG 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Life expectancy at birth</span></li><li><span style=\"font-size:12.0pt;\">Mean years of schooling</span></li><li><span style=\"font-size:12.0pt;\">Gross national product</span></li></ol>",
    "unique_key": "Q2992707",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175043,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) All three</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The Human Development Index (HDI) is a composite index used to measure the overall achievement of a country in three basic dimensions of human development:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Health:</strong> Measured by life expectancy at birth, which reflects the average number of years a newborn is expected to live if current mortality rates continue to apply.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Education:</strong> Measured by the mean years of schooling for adults aged 25 years or older and expected years of schooling for children entering school. This represent knowledge, enrolment ratio.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Living Standards:</strong> Measured by Gross National Income (GNI) per capita, expressed in terms of purchasing power parity (PPP) in US dollars.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These components together provide a summary measure of average achievement in key dimensions of human development, allowing for comparisons across countries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">HDI is calculated using three components: life expectancy at birth, mean years of schooling, and Gross National Income per capita. These factors represent health, education, and living standards, respectively.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>HDI range \u2013 0 to +1</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>HDI (India) \u2013 0.644 (Rank 134)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>HDI (Switzerland) \u2013 0.96 (Rank 1)</strong></span></li></ul>",
    "correct_choice_id": 229663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InstrumentsBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11056,
    "choices": [
      {
        "id": 44190,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">e-VIN</span></p>"
      },
      {
        "id": 44191,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Freeze indicator</span></p>"
      },
      {
        "id": 44192,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitor</span></p>"
      },
      {
        "id": 44193,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Fridge indicator</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are overseeing the arrival of vaccines at a remote clinic. To ensure the vaccines have maintained their potency during transit, which tool would you use? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q9599673",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175019,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Vaccine vial monitor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain.</span></li><li><span style=\"color:black;font-size:12.0pt;\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></li><li><span style=\"color:black;font-size:12.0pt;\">A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Expiry date can\u2019t be determined by VVM and has no relation to extend the expiry date.</span></li><li><span style=\"color:black;font-size:12.0pt;\">If the square and the circle are the same in colour or square is darker, then the vaccine should be discarded.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture52222.jpg\" alt=\"\" width=\"700\" height=\"370\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. e-VIN:&nbsp;</strong>e-VIN (Electronic Vaccine Intelligence Network) tracks the stock status and temperature of vaccine inventories via the internet, but it does not assess the viability of individual vaccine vials upon arrival.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Freeze indicator:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">Freeze indicator detects exposure to freezing temperatures, which can damage vaccines, but it does not indicate heat exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Fridge indicator:&nbsp;</strong>Fridge indicator monitors the temperature inside a refrigerator, ensuring it remains within a safe range but does not provide specific information about the exposure of individual vaccine vials during transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture422.jpg\" alt=\"\" width=\"800\" height=\"580\"></span></p>",
    "correct_choice_id": 44192,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InstrumentsBased"
    ]
  },
  {
    "id": 20348,
    "choices": [
      {
        "id": 81353,
        "text": "<p><span style=\"font-size:12.0pt;\">ANM</span></p>"
      },
      {
        "id": 81354,
        "text": "<p><span style=\"font-size:12.0pt;\">AWW</span></p>"
      },
      {
        "id": 81355,
        "text": "<p><span style=\"font-size:12.0pt;\">Trained birth attendant</span></p>"
      },
      {
        "id": 81356,
        "text": "<p><span style=\"font-size:12.0pt;\">ASHA</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-week primigravida c/o reduced vision at night. She has been avoiding papaya, mango, and other fruits throughout her pregnancy as she thinks they could be abortifacients. It is the primary duty of which of the following workers to provide counselling and information to the patient? (NEET PG 2023)</span></p>",
    "unique_key": "Q3720725",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175057,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) AWW</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The described scenario involves a pregnant woman with a misconception about the consumption of certain fruits during pregnancy and a symptom of night blindness, which could indicate a deficiency in Vitamin A. The <strong>Anganwadi Worker (AWW)</strong> is primarily responsible for providing health and nutrition education and counselling to mothers, which includes information about proper dietary practices during pregnancy. AWWs are trained to address specific local challenges that prevent healthy behaviors, such as cultural practices, myths, local food availability, and dietary practices.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>ANM (Auxiliary Nurse Midwife):&nbsp;</strong>ANMs primarily focus on providing basic medical care, immunizations, and assisting with childbirth and antenatal care. While they do offer some nutritional advice, the specific role of counselling about dietary misconceptions primarily falls under the AWW.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Trained birth attendant:&nbsp;</strong>Trained birth attendants are primarily involved in assisting with childbirth and ensuring safe delivery practices. Their role does not typically include extensive nutritional counselling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>ASHA (Accredited Social Health Activist):&nbsp;</strong>ASHAs work to promote community health and link the community with health services. They play a supportive role in health education, but detailed nutritional counselling is more specifically the responsibility of the AWW.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is the duty of the <strong>Anganwadi Worker (AWW)</strong> to provide health and nutrition education and counselling to pregnant women, addressing misconceptions about diet and ensuring they receive proper nutritional guidance. Their training includes addressing local challenges and cultural practices to promote healthy behaviors.</span></p>",
    "correct_choice_id": 81354,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10437,
    "choices": [
      {
        "id": 41714,
        "text": "<p><span style=\"font-size:12.0pt;\">1A</span></p>"
      },
      {
        "id": 41715,
        "text": "<p><span style=\"font-size:12.0pt;\">1B</span></p>"
      },
      {
        "id": 41716,
        "text": "<p><span style=\"font-size:12.0pt;\">2A</span></p>"
      },
      {
        "id": 41717,
        "text": "<p><span style=\"font-size:12.0pt;\">2B</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 5-year-old child, known to be underweight and experiencing difficulty seeing in low light, presents with significant dryness in the eyes. The child's diet is primarily carbohydrate-based with minimal intake of green vegetables and meat. What is the WHO grading for the child's ocular condition related to malnutrition? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q4704446",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175032,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. 1A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Child presents with dryness of eye, that is Conjunctival Xerosis (X1A)</span></li><li><span style=\"font-size:12.0pt;\">The symptom is consistent with <strong>early-stage Vitamin A deficiency</strong> caused by a malnourished diet.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Deficiency of Vitamin A leads to dryness of eyes or Xerophthalmia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-142748.jpg\" alt=\"\" width=\"700\" height=\"496\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 1B (X1B)</strong>: Represents Bitot's spots, which are more advanced than night blindness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-142806.jpg\" alt=\"\" width=\"700\" height=\"503\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 2A (X2)</strong>: Corneal xerosis, a later stage involving corneal dryness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 2B (X3A)</strong>: Involves corneal ulceration &lt;1/3, indicating severe deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>WHO Grading of Vitamin A Deficiency:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-16%20185830.jpg\" width=\"1039\" height=\"482\"></p>",
    "correct_choice_id": 41714,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 54762,
    "choices": [
      {
        "id": 218513,
        "text": "<p><span style=\"font-size:12.0pt;\">Microwaving and 95% ethanol</span></p>"
      },
      {
        "id": 218514,
        "text": "<p><span style=\"font-size:12.0pt;\">Autoclaving</span></p>"
      },
      {
        "id": 218515,
        "text": "<p><span style=\"font-size:12.0pt;\">Autoclaving and 70% ethanol</span></p>"
      },
      {
        "id": 218516,
        "text": "<p><span style=\"font-size:12.0pt;\">Hot air oven</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Sterilization technique for the tip of disposable glass pipette is:&nbsp;</span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2024)</span></p>",
    "unique_key": "Q3530522",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175047,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Autoclaving and 70% ethanol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most effective sterilization technique for the tip of disposable glass pipettes, as indicated by the available methods, is autoclaving in combination with 70% ethanol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Autoclaving is a reliable method of sterilization that involves exposing the material to high temperature and pressure (121\u00b0C at 15 psi) for a specific period, typically 20 minutes. This method effectively kills bacteria, viruses, and spores.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Chemical disinfectants</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-104212.png\" alt=\"\" width=\"1000\" height=\"213\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So, 70% ethanol is widely used as a disinfectant due to its ability to denature proteins and dissolve lipids, making it highly effective at eliminating microbial contamination on glass surfaces.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Microwaving and 95% ethanol</strong>: Microwaving is not a standard sterilization method for glass pipettes. Although 95% ethanol can be used for disinfection, it is less effective than 70% ethanol because it evaporates too quickly to kill all microbes thoroughly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Autoclaving</strong>: While autoclaving alone is an effective sterilization method, the question specifies the tip of disposable glass pipettes, where combining it with 70% ethanol enhances the sterilization process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hot air oven</strong>: A hot air oven can be used for sterilization, but it requires longer exposure times at higher temperatures. This method is less efficient compared to autoclaving combined with ethanol, especially for small, delicate items like pipette tips.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most effective sterilization technique for the tip of disposable glass pipettes is autoclaving combined with 70% ethanol. Autoclaving provides high heat and pressure to eliminate microorganisms, while 70% ethanol ensures thorough disinfection.</span></p>",
    "correct_choice_id": 218515,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11085,
    "choices": [
      {
        "id": 44306,
        "text": "<p><span style=\"font-size:12.0pt;\">\u20b9 500 is given per week</span></p>"
      },
      {
        "id": 44307,
        "text": "<p><span style=\"font-size:12.0pt;\">\u20b9 500 is given per month</span></p>"
      },
      {
        "id": 44308,
        "text": "<p><span style=\"font-size:12.0pt;\">Mid-day meals are given</span></p>"
      },
      {
        "id": 44309,
        "text": "<p><span style=\"font-size:12.0pt;\">Dietary advice is given</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient diagnosed with tuberculosis is learning about available government support for nutritional aid during treatment. Which of the following accurately represents a feature of the Nikshay Poshan Yojana? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q1734753",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175033,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) </strong>\u20b9 <strong>500 is given per month</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Nikshay Poshan Yojana provides nutritional support in the form of money to patients of TB.</span></li><li><span style=\"font-size:12.0pt;\">Patients receive \u20b9 500 per month under this scheme.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Nikshay Poshan Yojana:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Financial incentive of Rs 500/- per month for each notified TB patient for duration for which the patient is on anti-TB treatment</span></li><li><span style=\"font-size:12.0pt;\">All TB patients notified on or after 1st April 2018 including all existing TB patients under treatment are eligible to receive incentive</span></li></ul>",
    "correct_choice_id": 44307,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10470,
    "choices": [
      {
        "id": 41846,
        "text": "<p><span style=\"font-size:12.0pt;\">Awareness \u2013 interest \u2013 adoption \u2013 evaluation</span></p>"
      },
      {
        "id": 41847,
        "text": "<p><span style=\"font-size:12.0pt;\">Awareness- interest- evaluation- adoption</span></p>"
      },
      {
        "id": 41848,
        "text": "<p><span style=\"font-size:12.0pt;\">Evaluation \u2013 adoption \u2013 awareness \u2013 interest</span></p>"
      },
      {
        "id": 41849,
        "text": "<p><span style=\"font-size:12.0pt;\">Adoption- awareness- interest \u2013 evaluation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In the context of health education and behaviour change, consider a situation where a local health department in a city decided to address the rising cases of communicable diseases. They identified inadequate hand hygiene as a significant contributing factor. To address this, they organized a mass gathering to promote hand wash awareness. During this event, they employed a systematic approach to ensure maximum impact. They started by making people aware of the importance of hand hygiene, followed by sparking interest through demonstrations and interactive sessions. Subsequently, they gauged the audience's understanding and openness to the idea, and finally, they encouraged and supported the adoption of these practices in their daily routine. Based on this description, which of the following sequences of events in the behaviour change process is most appropriate? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q9599032",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175048,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Awareness-interest-evaluation-adoption</strong></span><span style=\"font-size:11pt;\">&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The behavior change process typically follows these stages:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Awareness:</strong> Making people aware of the importance of a behavior (hand hygiene).</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Interest:</strong> Sparking interest through engaging methods like demonstrations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Evaluation:</strong> Assessing the audience's understanding and willingness to adopt the behavior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adoption:</strong> Encouraging and supporting the adoption of the behavior in daily routines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5 stages are included in this process</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Awareness</span></li><li><span style=\"font-size:12.0pt;\">Interest</span></li><li><span style=\"font-size:12.0pt;\">Evaluation</span></li><li><span style=\"font-size:12.0pt;\">Trial</span></li><li><span style=\"font-size:12.0pt;\">Adoption</span></li></ul>",
    "correct_choice_id": 41847,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10233,
    "choices": [
      {
        "id": 40898,
        "text": "<p><span style=\"font-size:12.0pt;\">Killed and intramuscular</span></p>"
      },
      {
        "id": 40899,
        "text": "<p><span style=\"font-size:12.0pt;\">Live and subcutaneous</span></p>"
      },
      {
        "id": 40900,
        "text": "<p><span style=\"font-size:12.0pt;\">Live and intramuscular</span></p>"
      },
      {
        "id": 40901,
        "text": "<p><span style=\"font-size:12.0pt;\">Killed and subcutaneous</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An acute encephalitis outbreak has occurred within the community, prompting the initiation of a vaccination campaign. Which of the following is true about the vaccine given in this condition? (NEET PG 2021)</span></p>",
    "unique_key": "Q3952116",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175056,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: A) Killed and intramuscular</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The question is referring to Japanese Encephalitis (JE) outbreaks, which are not uncommon in India and parts of Southeast Asia. During such outbreaks, emergency vaccination campaigns are often undertaken to control the spread of disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most commonly used vaccine in these public health campaigns in India earlier used to be Live JE SA 14-14-2 vaccine (subcutaneous). But nowadays, the inactivated (killed) Vero cell\u2013derived JE vaccine - JENVAC is used intramuscularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, the correct response based on updated national guidelines is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Killed and intramuscular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B) Live and subcutaneous:</strong></span></p><p><span style=\"font-size:12.0pt;\">While the SA 14-14-2 vaccine is a live, attenuated vaccine given subcutaneously, recent protocols for outbreak settings increasingly prefer killed vaccines like JENVAC, especially in adult populations and for mass campaigns due to ease of storage and safety. Live vaccine SA -14-14-2 is quite good during outbreaks too. But JENVAC has an edge over SA 14-14-2 because of the higher immunity levels it creates with a single dose. Hence, although previously correct, SA 14-14-2 is no longer the preferred or updated answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C) Live and intramuscular:</strong></span></p><p><span style=\"font-size:12.0pt;\">Live vaccines (like SA 14-14-2) are given subcutaneously. IM route is not used for Live JE SA 14-14-2 routinely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D) Killed and subcutaneous:</strong></span></p><p><span style=\"font-size:12.0pt;\">Killed JE vaccines (like JENVAC or IXIARO) are administered intramuscularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the setting of a Japanese Encephalitis outbreak, the vaccine currently recommended and used in mass immunization campaigns in India is a killed (inactivated) vaccine administered via the intramuscular route, such as JENVAC. While older guidelines or some regions may have used the live attenuated SA 14-14-2 vaccine given subcutaneously, updated practices now favor the inactivated IM vaccine due to its broader safety profile and compatibility with adult vaccination. Always refer to the most recent national immunization guidelines when answering such public health\u2013related MCQs.</span></p>",
    "correct_choice_id": 40898,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11166,
    "choices": [
      {
        "id": 44630,
        "text": "<p><span style=\"font-size:12.0pt;\">Single male migrants</span></p>"
      },
      {
        "id": 44631,
        "text": "<p><span style=\"font-size:12.0pt;\">Truck drivers</span></p>"
      },
      {
        "id": 44632,
        "text": "<p><span style=\"font-size:12.0pt;\">STD clinic attendees</span></p>"
      },
      {
        "id": 44633,
        "text": "<p><span style=\"font-size:12.0pt;\">Antenatal woman</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A public health officer is reviewing populations targeted by the HIV sentinel surveillance program. Which group is NOT traditionally included in HIV sentinel surveillance? (INICET NOV 2020)</span></p>",
    "unique_key": "Q1452009",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175015,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) STD clinic attendees</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Routine monitoring for HIV is generally not conducted among individuals visiting STD clinics.</span></li><li><span style=\"font-size:12.0pt;\">Sentinel surveillance serves to enhance the existing notification systems employed for disease surveillance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Single male migrants:</strong> Included in sentinel surveillance as they are considered at high risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Truck drivers:</strong> Included due to their high-risk behavior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antenatal women:</strong> Included to monitor HIV prevalence among pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The sites for HIV sentinel surveillance includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A pregnant woman of reproductive age and attending the antenatal clinic for the first time.</span></li><li><span style=\"font-size:12.0pt;\">Female sex workers.</span></li><li><span style=\"font-size:12.0pt;\">Hijra/Transgenders.</span></li><li><span style=\"font-size:12.0pt;\">IV drug users</span></li><li><span style=\"font-size:12.0pt;\">Truckers.</span></li><li><span style=\"font-size:12.0pt;\">Homosexual Men</span></li><li><span style=\"font-size:12.0pt;\">Migrants.</span></li></ul>",
    "correct_choice_id": 44632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 57590,
    "choices": [
      {
        "id": 229729,
        "text": "<p><span style=\"font-size:12.0pt;\">Cultural barrier</span></p>"
      },
      {
        "id": 229730,
        "text": "<p><span style=\"font-size:12.0pt;\">Physiological barrier</span></p>"
      },
      {
        "id": 229731,
        "text": "<p><span style=\"font-size:12.0pt;\">Psychological barrier</span></p>"
      },
      {
        "id": 229732,
        "text": "<p><span style=\"font-size:12.0pt;\">Semantic barrier</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During a health education session, people cannot understand your few technical words during the chat, and it\u2019s a miscommunication. This is which type of barrier? (NEET PG 2024)</span></p>",
    "unique_key": "Q9166337",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175053,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Semantic barrier</strong></span></p><p><br><span style=\"font-size:12.0pt;\">A semantic barrier, also known as <strong>a linguistic barrier</strong>, arises when there is a difference in language or when technical jargon and complex terms are used that the audience cannot understand. This leads to miscommunication because the message is not clearly conveyed. In the given scenario, the use of technical words during the health education session caused a communication breakdown because the audience did not understand those terms. This is a classic example of a semantic barrier.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cultural barrier:</strong> A cultural barrier occurs when differences in customs, beliefs, caste or religion prevent effective communication. This is not the case here as the issue was related to language and technical terms, not cultural differences.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Physiological barrier:</strong> Physiological barriers include physical issues like hearing difficulties or speech impairments that obstruct communication. These are not relevant to the scenario described, where language misunderstanding was the primary issue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Psychological barrier:</strong> Psychological barriers stem from emotional disturbances, stress, or mental conditions that hinder effective communication. While these can affect communication, they are unrelated to the miscommunication caused by technical words in this example.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">A semantic barrier occurs when the use of complex language, technical terms, or unfamiliar words leads to misunderstanding and miscommunication.</span></p>",
    "correct_choice_id": 229732,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10254,
    "choices": [
      {
        "id": 40982,
        "text": "<p><span style=\"font-size:12.0pt;\">Cured</span></p>"
      },
      {
        "id": 40983,
        "text": "<p><span style=\"font-size:12.0pt;\">Treatment</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">completed</span></p>"
      },
      {
        "id": 40984,
        "text": "<p><span style=\"font-size:12.0pt;\">Lost to follow up</span></p>"
      },
      {
        "id": 40985,
        "text": "<p><span style=\"font-size:12.0pt;\">Treatment</span> <span style=\"font-size:12.0pt;\">failed</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A male patient who was diagnosed with tuberculosis has successfully completed the full course of treatment. Subsequent to finishing both the intensive and continuation phases, the initial sputum examination was conducted. The results of this examination were negative. What is the current condition of the patient?</span>&nbsp;(NEET PG 2022)</p>",
    "unique_key": "Q4093473",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175006,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cured</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A patient with negative sputum examination at the end of tuberculosis treatment indicates that the patient has been cured of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis that primarily affects the lungs and causes pulmonary tuberculosis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A TB case can be confirmed by positive results on smear microscopy and culture of biological specimens or diagnosed clinically by a clinician who prescribes a full course of TB treatment.</span></li><li><span style=\"font-size:12.0pt;\">TB treatment consists of two phases: the intensive phase lasting for two months and the continuation phase lasting for four months.</span></li><li><span style=\"font-size:12.0pt;\">Treatment involves four drugs in the intensive phase, namely isoniazid, rifampicin, pyrazinamide, and ethambutol, and isoniazid along with rifampicin and ethambutol in the continuation phase.</span></li><li><span style=\"font-size:12.0pt;\">After completion of treatment, the patient's sputum/culture is tested and assigned one of the following outcomes: cured, treatment completed, treatment failed, lost to follow-up, died, or not evaluated, depending on the results of the test and the patient's medical history.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Treatment Completed:&nbsp;</strong>Refers to a patient who has completed treatment without evidence of failure but lacks documented negative sputum smear or culture results in the last month of treatment and on at least one previous occasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Lost to Follow-Up:&nbsp;</strong>Refers to a patient who did not start treatment or whose treatment was interrupted for two consecutive months or more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Treatment Failed:&nbsp;</strong>Refers to a patient whose sputum smear or culture is still positive after 5 months or more of treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Terminologies:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Cured -</strong> A TB patient whose smear or culture turned negative in the last month of treatment and on at least one previous occasion</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment completed -</strong> A TB patient who completed treatment without any failure, but has no record to show that sputum smear or culture results in the last month of treatment and on at least one previous occasion were negative; it may be either because tests were not done or because results are unavailable</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment failed -</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">A TB patient whose sputum smear or culture is still positive after treatment for 5 months or more</span></li><li><span style=\"font-size:12.0pt;\"><strong>Lost to follow-up</strong> - A TB patient who did not start treatment or whose treatment was interrupted for 2 consecutive months or more</span></li><li><span style=\"font-size:12.0pt;\"><strong>Died -</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">A TB patient who dies before starting or during the course of treatment for any reason</span></li><li><span style=\"font-size:12.0pt;\"><strong>Not evaluated -</strong> A TB patient for whom no treatment outcome is assigned; this includes cases \"transferred out\" to another treatment unit and cases for whom the treatment outcome is unknown to the reporting unit whose treatment is interrupted</span></li></ul>",
    "correct_choice_id": 40982,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11125,
    "choices": [
      {
        "id": 44466,
        "text": "<p><span style=\"font-size:12.0pt;\">Both sensitivity and specificity increase</span></p>"
      },
      {
        "id": 44467,
        "text": "<p><span style=\"font-size:12.0pt;\">Both sensitivity and specificity decrease</span></p>"
      },
      {
        "id": 44468,
        "text": "<p><span style=\"font-size:12.0pt;\">Sensitivity increases while specificity decreases</span></p>"
      },
      {
        "id": 44469,
        "text": "<p><span style=\"font-size:12.0pt;\">Sensitivity decreases while specificity increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A new diagnostic test for dengue is being evaluated using a Receiver Operating Characteristic (ROC) graph. As the curve transitions from the green region to the pink region, what is the most likely change in the test characteristics? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip30.jpg\" alt=\"\" width=\"532\" height=\"383\"></p>",
    "unique_key": "Q1256811",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175052,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Both sensitivity and specificity increase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As the curve transitions from green to pink, both sensitivity and specificity experience an increase.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Sensitivity</strong>: Ability of a screening test to identify correctly all those who have the disease (cases)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i>Sensitivity = a/ (a + c) \u00d7 100 = TP/ (TP + FN) \u00d7 100</i></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Specificity</strong>: Ability of a screening test to identify correctly all those who do not have the disease (healthy)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i>Specificity = d/ (b + d) \u00d7 100 = TN/ (TN + FP) \u00d7 100</i></span></p><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100044.png\" alt=\"\" width=\"400\" height=\"218\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As the curve transitions from green to pink, it increases the count of true positives and negatives while decreases the occurrences of false positives and negatives. Consequently, this shift results in increased sensitivity and specificity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100216.png\" alt=\"\" width=\"700\" height=\"197\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">On an ROC graph, a transition from one region to another indicating improved test performance generally means that both sensitivity and specificity are increasing.</span></li></ul>",
    "correct_choice_id": 44466,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 11189,
    "choices": [
      {
        "id": 44722,
        "text": "<p><span style=\"font-size:12.0pt;\">Disaster response</span></p>"
      },
      {
        "id": 44723,
        "text": "<p><span style=\"font-size:12.0pt;\">Disaster reconstruction</span></p>"
      },
      {
        "id": 44724,
        "text": "<p><span style=\"font-size:12.0pt;\">Disaster rehabilitation</span></p>"
      },
      {
        "id": 44725,
        "text": "<p><span style=\"font-size:12.0pt;\">Disaster mitigation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old civil engineer is working on a construction project in an area recently affected by a devastating earthquake. To prevent future devastation, the local government has amended the building codes. These changes are aimed at ensuring structures in the area can better withstand seismic activity. The engineer reviews the changes to determine the best approach for the new construction project. This modification to the building codes is primarily an example of which phase of disaster management? (INICET NOV 2022)</span></p>",
    "unique_key": "Q7758821",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175023,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Disaster mitigation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The measures that are taken to prevent disasters from causing emergencies or to lessen the likely effects of emergencies are part of disaster mitigation.</span></li><li><span style=\"font-size:12.0pt;\">Mitigation involves measures designed either to prevent hazards from causing an emergency or to lessen the likely effects of emergencies. In most cases mitigation measures aim to reduce the vulnerability of the system.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Disaster Cycle, the steps involved are \u2013</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Disaster Impact and Response:&nbsp;</strong>it involves search, rescue, first aid of the patients, triaging them according to the severity of their injuries and their likelihood of survival with prompt medical intervention, tagging and identification of dead.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relief Phase or Disaster Containment&nbsp;</strong>by prompt assistance, epidemiological surveillance and disease control, vaccination, nutritional support.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Rehabilitation&nbsp;</strong>involves restoration of the pre-disaster conditions. It takes into account assessment and restoration of water supply, food safety and supply, basic sanitation, personal hygiene, vector control.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Disaster Mitigation&nbsp;</strong>involves<strong> </strong>measures<strong> </strong>aimed at reducing or preventing the hazards from causing any emergency or to dampen the effects of emergencies. It involves flood mitigation works, appropriate land-use planning, improved building codes and reduction or protection of vulnerable population and structures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Disaster Preparedness&nbsp;</strong>is a long-term programme of developmental activities which aims at strengthening the overall capacity and capability of the country to efficiently and effectively manage all the emergencies.<strong>&nbsp;</strong>&nbsp;</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp; <img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/whatsapp-image-2023-10-20-at-173957.jpeg\" alt=\"\" width=\"500\" height=\"534\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Disaster mitigation involves proactive measures such as improved building codes to reduce the impact of future disasters, aiming to lessen vulnerability and enhance resilience against potential hazards.</span></li></ul>",
    "correct_choice_id": 44725,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 54761,
    "choices": [
      {
        "id": 218509,
        "text": "<p><span style=\"font-size:12.0pt;\">Molybdenum</span></p>"
      },
      {
        "id": 218510,
        "text": "<p><span style=\"font-size:12.0pt;\">Copper</span></p>"
      },
      {
        "id": 218511,
        "text": "<p><span style=\"font-size:12.0pt;\">Zinc</span></p>"
      },
      {
        "id": 218512,
        "text": "<p><span style=\"font-size:12.0pt;\">Magnesium</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Mineral deficiency clinically found to be associated with sexual dysfunction is:&nbsp;</span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2024)</span></p>",
    "unique_key": "Q2512453",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175050,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Zinc</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc deficiency is well-documented to be associated with <strong>several reproductive and sexual health issues.</strong> It is particularly known for causing <strong>Acrodermatitis Enteropathica</strong>, a rare genetic disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc deficiency can lead to sexual infantilism, sterility, diarrhea, brittle nails, loss of taste, growth failure, etc. Additionally, zinc is crucial for maintaining healthy testosterone levels, which is vital for sexual health in both men and women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnancy, zinc deficiency can result in <strong>low birth weight, intrauterine growth restriction (IUGR), congenital malformations, and even spontaneous abortions</strong>, further highlighting its critical role in reproductive health.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Molybdenum</strong>: Molybdenum deficiency is associated with conditions such as <strong>mouth or esophageal cancer and respiratory and neurological issues</strong>. There is no direct link between molybdenum deficiency and sexual dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Copper</strong>: Copper deficiency can lead to <strong>anemia, bone fractures, neutropenia, osteoporosis, depigmentation of the skin, and thyroid issues</strong>. However, it is not linked to sexual dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Magnesium</strong>: Magnesium deficiency is primarily associated with <strong>irritability, tetany, hyperreflexia, and impaired metabolism of potassium and calcium.</strong> It does not have a direct connection with sexual dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sexual dysfunction occur due to deficiency of Zinc, calcium, Vitamin D and B12. Essential fatty acid deficiency may also be associated with sexual dysfunction.</span></p>",
    "correct_choice_id": 218511,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11152,
    "choices": [
      {
        "id": 44574,
        "text": "<p><span style=\"font-size:12.0pt;\">A child &lt; 2 years</span></p>"
      },
      {
        "id": 44575,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient with sickle cell disease</span></p>"
      },
      {
        "id": 44576,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient with cystic fibrosis</span></p>"
      },
      {
        "id": 44577,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient with recurrent otitis media</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A new vaccine has been developed to target the 23 serotypes of <i>Streptococcus pneumoniae</i>. This polysaccharide vaccine promises to reduce the morbidity and mortality associated with pneumococcal infections, particularly in certain high-risk groups. Which of the following patient groups would most likely derive the most benefit from this vaccine? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q2616853",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175009,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) A patient with sickle cell disease&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The polysaccharide vaccine targeting Streptococcus pneumoniae (PPSV-23) provides the greatest advantages to individuals with sickle cell disease.</span></li><li><span style=\"font-size:12.0pt;\">Streptococcus pneumoniae is a bacteria enveloped in a protective layer that the spleen recognizes and eliminates.</span></li><li><span style=\"font-size:12.0pt;\">However, in the case of sickle cell disease, the distorted shape of red blood cells obstructs the spleen's blood vessels, leading to damage.</span></li><li><span style=\"font-size:12.0pt;\">This compromised spleen function, known as hyposplenism, raises the susceptibility to pneumococcal infections.</span></li><li><span style=\"font-size:12.0pt;\">Consequently, sickle cell patients receive the pneumococcal vaccine (PPSV-23) as a preventive measure, aimed at diminishing this vulnerability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. A child &lt; 2 years:&nbsp;</strong>Polysaccharide vaccines are not effective in children under 2 years old due to their immature immune systems. Conjugate vaccines are preferred for this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. A patient with cystic fibrosis:&nbsp;</strong>While at risk for lung infections, cystic fibrosis patients benefit more from vaccines targeting typical respiratory pathogens, and their spleen function is usually normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. A patient with recurrent otitis media:&nbsp;</strong>This condition is typically managed with other interventions, and the need for a polysaccharide vaccine is less critical.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The PPSV-23 vaccine is most beneficial for patients with sickle cell disease due to their increased susceptibility to pneumococcal infections caused by compromised spleen function.</span></li></ul>",
    "correct_choice_id": 44575,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10200,
    "choices": [
      {
        "id": 40766,
        "text": "<p><span style=\"font-size:12.0pt;\">1 year</span></p>"
      },
      {
        "id": 40767,
        "text": "<p><span style=\"font-size:12.0pt;\">2 years</span></p>"
      },
      {
        "id": 40768,
        "text": "<p><span style=\"font-size:12.0pt;\">3 years</span></p>"
      },
      {
        "id": 40769,
        "text": "<p><span style=\"font-size:12.0pt;\">4 years</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An employee who has been diagnosed with tuberculosis is eligible for an extended sickness benefit for? (NEET PG 2020)</span></p>",
    "unique_key": "Q3100071",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175038,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the Employees' State Insurance (ESI) Act of 1948, employees who are diagnosed with specific long-term illnesses, including tuberculosis, are eligible for an extended sickness benefit. This benefit provides financial support to cover a significant portion of their wages during prolonged periods of illness. The extended sickness benefit offers 80% of the employee's wages for up to 2 years. This provision ensures that employees have continued financial support while they are unable to work due to their medical condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-134020.jpg\" alt=\"\" width=\"1000\" height=\"318\"></span></p>",
    "correct_choice_id": 40767,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11073,
    "choices": [
      {
        "id": 44258,
        "text": "<p><span style=\"font-size:12.0pt;\">100</span></p>"
      },
      {
        "id": 44259,
        "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
      },
      {
        "id": 44260,
        "text": "<p><span style=\"font-size:12.0pt;\">250</span></p>"
      },
      {
        "id": 44261,
        "text": "<p><span style=\"font-size:12.0pt;\">160</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A drug trial was initiated under Medicine department to test the efficacy of a new medication in comparison to a placebo. The participants were divided into two cohorts. Cohort A received a placebo, while cohort B was treated with the novel drug. Out of the 120 participants in cohort A, 36 faced fatal outcomes. In cohort B, with 130 participants, there were 26 fatal outcomes. Given this data, if a clinician were to incorporate this novel medication into practice, how many patients would they need to treat with this new medication to prevent one additional fatality when compared to the placebo group? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q2312613",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175030,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 10</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">10 patients need to be treated with the new drug to avert 1 death.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">We can group divide the case scenario into two groups:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Experimental (New treatment) group \u2013 26 Treatment failures out of 130</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Control (Old treatment) group \u2013 36 Treatment failures out of 120</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124705.jpg\" alt=\"\" width=\"700\" height=\"184\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Now, we have to calculate failure rate in both groups:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Experimental (New treatment) group \u2013 26/130 = 0.2</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Control (Old treatment) group \u2013 36/120 = 0.3</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;<strong>Absolute risk reduction (ARR) </strong>is the difference of failure in both groups = 0.3 \u2013 0.2 = 0.1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Number needed to treat (NNT) = 1/ARR </strong>= 1/0.1 = 10</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Number Needed to Treat (NNT) is a practical measure used in decision-making for clinical interventions.</span></li><li><span style=\"font-size:12.0pt;\">It represents the number of patients that need to be treated with a particular therapy over a specific period to prevent one additional bad outcome, such as death in this scenario.</span></li><li><span style=\"font-size:12.0pt;\">An NNT of 10 indicates that the new medication has a significant impact in reducing fatalities compared to the placebo.</span></li></ul>",
    "correct_choice_id": 44259,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 46454,
    "choices": [
      {
        "id": 185435,
        "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine X 6 weeks</span></p>"
      },
      {
        "id": 185436,
        "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine X 6 months</span></p>"
      },
      {
        "id": 185437,
        "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine + Zidovudine X 6 weeks</span></p>"
      },
      {
        "id": 185438,
        "text": "<p><span style=\"font-size:12.0pt;\">Nevirapine + Zidovudine X 6 months</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">HIV positive woman, not on any treatment, delivers a baby. Initial treatment for the newborn will include:(FMGE JULY 2023)</span></p>",
    "unique_key": "Q7948868",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175055,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C)&nbsp;Nevirapine + Zidovudine X 6 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Low-risk infants:&nbsp;</strong></span></p><ul><li><span style=\"font-size:16px;\">Infants born to mothers with suppressed viral load (&lt;1000 copies/ml) done any time after 32 weeks of pregnancy up to delivery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>ARV Prophylaxis Options:</u></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Syrup Nevirapine (NVP) or</span></li><li><span style=\"font-size:16px;\">Syrup Zidovudine# (in situations where NVP will not be effective):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Infant born to a mother with confirmed HIV-2 or HIV-1 and HIV-2 combined infections</span></li><li><span style=\"font-size:16px;\">Infant born to a mother who had received single dose of NVP during earlier pregnancy or delivery</span></li><li><span style=\"font-size:16px;\">Infant born to a mother who is on PI-based ART regimen due to treatment failure</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>Duration of ARV prophylaxis:</u></span></p><ul><li><span style=\"font-size:16px;\">From birth till 6 weeks of age</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>High-risk infants</strong></span></p><ul><li><span style=\"font-size:16px;\">Infants born to HIV-positive mother not on ART</span></li><li><span style=\"font-size:16px;\">Maternal viral load not done after 32 weeks of pregnancy till delivery</span></li><li><span style=\"font-size:16px;\">Maternal viral load not suppressed between 32 weeks of pregnancy till delivery</span></li><li><span style=\"font-size:16px;\">Mother newly identified HIV positive within 6 weeks of delivery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>Options for dual prophylaxis:</u></span></p><ul><li><span style=\"font-size:16px;\">Syrup NVP + Syrup Zidovudine</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><u>Duration of Dual ARV Prophylaxis:</u></span></p><ul><li><span style=\"font-size:16px;\">In case of Exclusive Replacement Feeding (ERF): From birth till 6 weeks of age</span></li><li><span style=\"font-size:16px;\">In case of Exclusive Breastfeeding (EBF): From birth till 12 weeks of age</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">For newborns of untreated HIV-positive mothers, initial treatment includes Syrup NVP + Syrup Zidovudine 6 weeks (12 weeks in cases of exclusive breast feeding) to reduce the risk of mother-to-child HIV transmission.</span></p>",
    "correct_choice_id": 185437,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 11086,
    "choices": [
      {
        "id": 44310,
        "text": "<p><span style=\"font-size:12.0pt;\">Polysaccharide vaccine</span></p>"
      },
      {
        "id": 44311,
        "text": "<p><span style=\"font-size:12.0pt;\">Toxoid</span></p>"
      },
      {
        "id": 44312,
        "text": "<p><span style=\"font-size:12.0pt;\">Killed vaccine</span></p>"
      },
      {
        "id": 44313,
        "text": "<p><span style=\"font-size:12.0pt;\">Live attenuated vaccine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A healthcare professional is reviewing vaccine protocols to update patient information materials. In doing so, she focuses on the type of vaccine used for diphtheria prevention. Which option correctly describes the type of diphtheria vaccine? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q2354757",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175034,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Toxoid</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The diphtheria vaccine is a <strong>toxoid vaccine</strong>, which involves the use of toxins produced by the bacterium that causes the disease.</span></li><li><span style=\"font-size:12.0pt;\">These toxins are chemically inactivated to form toxoids, which are safe for use in vaccines but still capable of eliciting a strong immune response.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Types of vaccine -&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-145824.png\" alt=\"\" width=\"1000\" height=\"534\"></p>",
    "correct_choice_id": 44311,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10434,
    "choices": [
      {
        "id": 41702,
        "text": "<p><span style=\"font-size:12.0pt;\">Gloves</span></p>"
      },
      {
        "id": 41703,
        "text": "<p><span style=\"font-size:12.0pt;\">Urine Bag</span></p>"
      },
      {
        "id": 41704,
        "text": "<p><span style=\"font-size:12.0pt;\">Sharps</span></p>"
      },
      {
        "id": 41705,
        "text": "<p><span style=\"font-size:12.0pt;\">Blood Bag</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rahul, a diligent hospital staff member in New Delhi, is responsible for ensuring the proper disposal of biomedical waste. Every day, he's faced with a myriad of items that need to be correctly sorted to maintain the hospital's adherence to waste management guidelines. Today, he encountered an array of items, and he had to determine which of these should be placed in the yellow bin, designated for specific biomedical wastes. Which of the following items should Rahul discard in the yellow bin? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q5068801",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175031,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Blood bag</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The yellow bin in biomedical waste management is designated for items such as human anatomical waste, soiled waste, and certain clinical wastes that include microbiological collections and used blood bags. Blood bags, which contain remnants of blood and other bodily fluids, are categorized under this type because of the high risk of contamination and the need for incineration or deep burial as per management guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/03/screenshot-2023-11-02-114110.jpg\" alt=\"\" width=\"700\" height=\"552\"></span></p>",
    "correct_choice_id": 41705,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 49026,
    "choices": [
      {
        "id": 195679,
        "text": "<p><span style=\"font-size:12.0pt;\">To cure disease</span></p>"
      },
      {
        "id": 195680,
        "text": "<p><span style=\"font-size:12.0pt;\">Do nothing to prolong life</span></p>"
      },
      {
        "id": 195681,
        "text": "<p><span style=\"font-size:12.0pt;\">To improve quality of life patient</span></p>"
      },
      {
        "id": 195682,
        "text": "<p><span style=\"font-size:12.0pt;\">Nothing is done in palliative care</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old male with a history of stage IV non-small cell lung cancer presents with worsening dyspnea, non-productive cough, and uncontrolled pain despite current medication. He has declined further aggressive treatment. What stands true for Palliative care?&nbsp;(INICET NOV 2023)</span></p>",
    "unique_key": "Q5630137",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175003,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) To improve quality of life patient</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Palliative care is a specialized medical care focused on providing relief from the symptoms and stress of a serious illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary goal of palliative care is <strong>to improve the quality of life for the patient</strong>. It involves treating pain and other distressing symptoms, providing psychological and spiritual care, and supporting the patient and their family to cope with the challenges of a serious illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. To cure disease</strong>: This is incorrect. Palliative care does not aim to cure the underlying disease but focuses on alleviating symptoms and improving the quality of life for both the patient and their family.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Do nothing to prolong life</strong>: Palliative care does not necessarily aim to prolong life, nor does it hasten death. It\u2019s about enhancing the quality of life and may also indirectly prolong it by improving general health and well-being.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nothing is done in palliative care</strong>: This is incorrect. Palliative care involves active and comprehensive management of various issues that arise with serious illnesses, including physical, emotional, social, and spiritual aspects of care.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective </strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Palliative care is crucial for improving the quality of life for patients with serious illnesses. It addresses a wide range of needs, ensuring the patient\u2019s comfort and supporting the family through difficult times, emphasizing symptom management and personal support over curative treatments.</span></p>",
    "correct_choice_id": 195681,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11176,
    "choices": [
      {
        "id": 44670,
        "text": "<p><span style=\"font-size:12.0pt;\">Stability</span></p>"
      },
      {
        "id": 44671,
        "text": "<p><span style=\"font-size:12.0pt;\">Objectivity</span></p>"
      },
      {
        "id": 44672,
        "text": "<p><span style=\"font-size:12.0pt;\">Generalizability</span></p>"
      },
      {
        "id": 44673,
        "text": "<p><span style=\"font-size:12.0pt;\">Repeatability</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are a public health researcher evaluating a new screening test for early detection of a specific disease in a community. Your team successfully conducted a pilot study in a small group. Before planning a large-scale implementation, you wish to ensure that the findings from your pilot study can be applied to larger, diverse groups of individuals outside your initial sample. This ability to extrapolate the findings in the broader population, i.e. the external validity of a screening test is related to which of the following options?&nbsp;(INICET NOV 2021)</span></p>",
    "unique_key": "Q7273815",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175017,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Generalizability</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Generalizability refers to the extent to which the findings from a study or pilot test can be applied to a broader population.</span></li><li><span style=\"font-size:12pt;\">It is a measure of the external validity of a study.</span></li><li><span style=\"font-size:12pt;\">Ensuring that the results of a pilot study can be extrapolated to larger, diverse groups outside the initial sample is crucial for the success of large-scale implementations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Stability:</strong> Refers to the consistency of test results over time, ensuring that repeated measurements yield the same results under unchanged conditions. While important, it does not address how findings apply to different populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Objectivity:</strong> Ensures that test results are unbiased and not influenced by the person administering the test. While critical for reliable results, it does not relate to applying findings to a broader population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Repeatability:</strong> Refers to the consistency of the test results when repeated under identical conditions. This is crucial for reliability but does not address the applicability of the results to different populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">External validity of a screening test is related to generalizability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Validity refers to what extent the test measures which it purports to measure (adequacy of measurement).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Types of Validity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/screenshot-2023-10-28-131034.jpg\" alt=\"\" width=\"800\" height=\"346\"></strong></span></p>",
    "correct_choice_id": 44672,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11057,
    "choices": [
      {
        "id": 44194,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Panchayat Health Committee</span></p>"
      },
      {
        "id": 44195,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Village Health Planning and Management Committee</span></p>"
      },
      {
        "id": 44196,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Rogi Kalyan Samiti</span></p>"
      },
      {
        "id": 44197,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Village Health Sanitation and Nutrition Committee</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As part of a health development project in rural India, you're asked about the key community group responsible for overseeing local health, sanitation, and nutrition initiatives. Which committee best fits this description? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q8654524",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175020,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Village Health Sanitation and Nutrition Committee</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">One of the key elements of the National Rural Health Mission is the Village Health, Sanitation and Nutrition committee (VHSNC).</span></li><li><span style=\"color:black;font-size:12.0pt;\">The committee has been formed to take collective actions on issues related to health and its social determinants at the village level.</span></li><li><span style=\"color:black;font-size:12.0pt;\">They are particularly envisaged as being central to \u2018local level community action\u2019 under NRHM, which would develop to support the process of Decentralized Health Planning.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Thus VHSNC is envisaged to take leadership in providing a platform for improving health awareness and access of community for health services, address specific local needs and serve as a mechanism for community based planning and monitoring.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The committee is formed at the revenue village level and it should act as a sub-committee of the Gram Panchayat.</span></li><li><span style=\"color:black;font-size:12.0pt;\">It should have a minimum of 15 members which should comprise of elected member of the Panchayat who shall lead the committee, all those working for health and health related services should participate, community members/ beneficiaries and representation from all community sub-groups especially the vulnerable sections and hamlets/ habitations. ASHA residing in the village shall be the member secretary and convener of the committee.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">&nbsp;<strong>ROLES AND RESPONSIBILITIES&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Create awareness about nutritional issues and significance of nutrition as an important determinant of health.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Carry out survey on nutritional status and nutritional deficiencies in the village especially among women and children.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Identify locally available food stuffs of high nutrient value as well as disseminate and promote best practices (traditional wisdom) congruent with local culture, capabilities and physical environment through a process of community consultation.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Inclusion of Nutritional needs in the Village Health Plan \u2013 The committee will do an in-depth analysis of causes of malnutrition at the community and household levels, by involving the ANM, AWW, ASHA and ICDS Supervisors.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Monitoring and Supervision of Village Health and Nutrition Day to ensure that it is organized every month in the village with the active participation of the whole village.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Facilitate early detection of malnourished children in the community; tie up referral to the nearest Nutritional Rehabilitation Centre (NRC) as well as follow up for sustained outcome.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Supervise the functioning of Anganwadi Centre (AWC) in the village and facilitate its working in improving nutritional status of women and children.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Act as a grievances redressal forum on health and nutrition issues.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Panchayat Health Committee&nbsp;</strong>and <strong>Option B. Village Health Planning and Management Committee&nbsp;</strong>generally refer to broader terms, but they do not specifically target the integrated approach of the VHSNC.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C. Rogi Kalyan Samiti (Patient Welfare Committee) / Hospital Management Committee&nbsp;</strong>is a simple yet effective management structure. This committee, a registered society, acts as a group of trustees for the hospitals to manage the affairs of the hospital. It consists of members from local Panchayati Raj Institutions (PRIs), NGOs, local elected representatives and officials from Government sector who are responsible for proper functioning and management of the hospital / Community Health Centre / FRUs. RKS / HMS is free to prescribe, generate and use the funds with it as per its best judgement for smooth functioning and maintaining the quality of services.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The VHSNC plays a crucial role in the grassroots-level health planning and implementation in rural India, ensuring that health initiatives are tailored to the specific needs and conditions of the community.</span></li><li><span style=\"font-size:12pt;\">It is a vital part of the health ecosystem, facilitating a comprehensive approach to public health management in rural settings.</span></li></ul>",
    "correct_choice_id": 44197,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11177,
    "choices": [
      {
        "id": 44674,
        "text": "<p><span style=\"font-size:12.0pt;\">Phosphatase test</span></p>"
      },
      {
        "id": 44675,
        "text": "<p><span style=\"font-size:12.0pt;\">lodine test</span></p>"
      },
      {
        "id": 44676,
        "text": "<p><span style=\"font-size:12.0pt;\">Standard plate count</span></p>"
      },
      {
        "id": 44677,
        "text": "<p><span style=\"font-size:12.0pt;\">Methylene blue reduction test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are a nutritionist giving a lecture about milk pasteurization and its quality assurance tests. A curious student inquires about the various tests to validate the efficacy of pasteurization. You begin to list them, but highlight one that is not directly related to the pasteurization process. Which of the following tests does not directly evaluate the efficiency of milk pasteurization? (INICET NOV 2021)</span></p>",
    "unique_key": "Q7918606",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175018,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) lodine test&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Given tests are associated with the milk pasteurization process except for the iodine test.</span></li><li><span style=\"font-size:12.0pt;\">This test is conducted to examine the potential adulteration of milk with starch or cereal flour.</span></li><li><span style=\"font-size:12.0pt;\">Iodine test - The presence of addition of starch in milk can be detected using an iodine test.</span></li><li><span style=\"font-size:12.0pt;\">When two or three drops of iodine solution is added to milk taken in a test tube, the solution turns dark blue.</span></li><li><span style=\"font-size:12.0pt;\">This shows the presence of starch mixed with the milk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Phosphatase Test:</strong> Used to check for the presence of the enzyme phosphatase, which should be inactivated by proper pasteurization. This ensures that the milk has been heated sufficiently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Standard Plate Count:</strong> Measures the total bacterial count to ensure it meets the standards for pasteurized milk. A lower count indicates effective pasteurization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Methylene Blue Reduction Test:</strong> Measures the time it takes for methylene blue to lose its color, which correlates with bacterial activity; high counts indicate inadequate pasteurization. This test helps verify the reduction of microbial load.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>PASTEURIZATION TESTS:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Phosphatase Test: Widely used test</span></li><li><span style=\"font-size:12.0pt;\">Standard Plate Count: Standard is coliforms be absent in 1 ml of milk</span></li><li><span style=\"font-size:12.0pt;\">Methylene blue reduction test: Enforced limit is 30,000 bacterial count per ml of pasteurized milk</span></li></ol>",
    "correct_choice_id": 44675,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 55447,
    "choices": [
      {
        "id": 221249,
        "text": "<p><span style=\"font-size:12.0pt;\">0.5</span></p>"
      },
      {
        "id": 221250,
        "text": "<p><span style=\"font-size:12.0pt;\">1.0</span></p>"
      },
      {
        "id": 221251,
        "text": "<p><span style=\"font-size:12.0pt;\">1.5</span></p>"
      },
      {
        "id": 221252,
        "text": "<p><span style=\"font-size:12.0pt;\">Cannot be calculated</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In a cohort study done in a community, out of those 100 vaccinated for malaria, only 6 developed the disease. At the same time, out of those 100 non-vaccinated, a total of 12 developed the disease. Find the relative risk in the study:&nbsp; (FMGE JULY 2024)</span></p>",
    "unique_key": "Q6656809",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175010,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) 0.5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To find the relative risk (RR) in this study, we first need to calculate the incidence of the disease in both the vaccinated (exposed) and non-vaccinated (non-exposed) groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 1: Incidence in the vaccinated group (exposed):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Number of vaccinated individuals = 100</span></li><li><span style=\"font-size:12.0pt;\">Number of vaccinated individuals who developed the disease = 6</span></li><li><span style=\"font-size:12.0pt;\">Incidence in the vaccinated group = 6/100 = 0.06</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 2: Incidence in the non-vaccinated group (non-exposed):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Number of non-vaccinated individuals = 100</span></li><li><span style=\"font-size:12.0pt;\">Number of non-vaccinated individuals who developed the disease = 12</span></li><li><span style=\"font-size:12.0pt;\">Incidence in the non-vaccinated group = 12/100 = 0.12</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 3: Calculate Relative Risk (RR):</strong></span><br>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">RR = Incidence in the exposed group / Incidence in the non-exposed group</span></li><li><span style=\"font-size:12.0pt;\">RR = 0.06 / 0.12 = 0.5</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The relative risk of 0.5 indicates that the vaccinated individuals were half as likely to develop malaria compared to those who were not vaccinated. This suggests a protective effect of the vaccine against malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a cohort study, the relative risk is calculated by comparing the incidence of the outcome in the exposed group to the incidence in the non-exposed group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A relative risk less than 1 indicates a protective effect of the exposure, as seen in this example where vaccination reduced the risk of malaria.</span></p>",
    "correct_choice_id": 221249,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 11108,
    "choices": [
      {
        "id": 44398,
        "text": "<p><span style=\"font-size:12.0pt;\">Screening tests define risk of passing genetic disorder</span></p>"
      },
      {
        "id": 44399,
        "text": "<p><span style=\"font-size:12.0pt;\">Screening tests are more accurate than diagnostic tests</span></p>"
      },
      {
        "id": 44400,
        "text": "<p><span style=\"font-size:12.0pt;\">Screening requires genetic mapping</span></p>"
      },
      {
        "id": 44401,
        "text": "<p><span style=\"font-size:12.0pt;\">Involve invasive procedures</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A genetic counsellor is discussing various types of genetic tests with a couple planning for a child. Which of the following statements accurately describes genetic screening? (INICET MAY 2022)</span></p>",
    "unique_key": "Q9128427",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175035,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Screening tests define risk of passing genetic disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Genetic screening/testing</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Genetic testing is a type of medical test that identifies changes in genes, chromosomes, or proteins.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">It is a process to analyse blood or skin for the systematic search for persons with a particular genotype in a defined population (usually invasive procedures)</span></li><li><span style=\"font-size:12.0pt;\">In order to locate this faulty gene, scientists search for variations in larger pieces of DNA called \"markers\", latter are found nearby the DNA and become the basis of genetic screening</span></li><li><span style=\"font-size:12.0pt;\">The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Screening tests are more accurate than diagnostic tests:</strong> Incorrect. Screening tests assess risk and are not as definitive as diagnostic tests, which provide a precise diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Screening requires genetic mapping:</strong> Incorrect. Genetic screening does not necessarily involve genetic mapping, which is a detailed analysis of the entire genome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Involve invasive procedures:</strong> Incorrect. Screening tests can often be performed using non-invasive methods such as blood or saliva samples, although some genetic tests may require invasive procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Genetic screening tests are used to define the risk of passing on a genetic disorder and can help determine the likelihood of developing a genetic condition.</span></li><li><span style=\"font-size:12.0pt;\">They are not as definitive as diagnostic tests and do not necessarily involve invasive procedures or genetic mapping.</span></li></ul>",
    "correct_choice_id": 44398,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 55429,
    "choices": [
      {
        "id": 221177,
        "text": "<p><span style=\"font-size:12.0pt;\">BOAA</span></p>"
      },
      {
        "id": 221178,
        "text": "<p><span style=\"font-size:12.0pt;\">Sanguinarine</span></p>"
      },
      {
        "id": 221179,
        "text": "<p><span style=\"font-size:12.0pt;\">Ergot toxin</span></p>"
      },
      {
        "id": 221180,
        "text": "<p><span style=\"font-size:12.0pt;\">Aflatoxin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A woman purchased a food item from a shopkeeper who was subsequently arrested for food adulteration. Meanwhile, the woman develops visual disturbances and cardiac failure. The underlying toxin is: (FMGE JULY 2024)</span></p>",
    "unique_key": "Q9353612",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175004,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Sanguinarine</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The question describes a case of food adulteration that led to symptoms such as visual disturbances (Glaucoma) and cardiac failure. These symptoms are characteristic of a condition known as <strong>epidemic dropsy</strong>, which is caused by the consumption of <strong>adulterated mustard oil.</strong> The toxic adulterant in this case is <strong>Argemone mexicana oil</strong>, which contains the toxin sanguinarine. Sanguinarine inhibits the oxidation of pyruvic acid in the blood, leading to the symptoms observed in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. BOAA</strong>: This is a toxin found in <i><strong>Lathyrus sativus</strong></i><strong> (Khesari dal)</strong> and can lead to neurolathyrism, a condition characterized by neuromuscular symptoms, not by visual disturbances or cardiac failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ergot toxin</strong>: This toxin is associated with ergotism, which causes symptoms like hallucinations, gangrene, and convulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aflatoxin</strong>: Aflatoxin is a mycotoxin produced by Aspergillus species, often found in improperly stored food items like grains and nuts. It is a potent carcinogen but does not cause the acute symptoms described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Food Adulteration diseases:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-134039.png\" alt=\"\" width=\"1000\" height=\"355\"></strong></span></p>",
    "correct_choice_id": 221178,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 24754,
    "choices": [
      {
        "id": 98977,
        "text": "<p><span style=\"font-size:12.0pt;\">Unequal precision band</span></p>"
      },
      {
        "id": 98978,
        "text": "<p><span style=\"font-size:12.0pt;\">Hirshberg band</span></p>"
      },
      {
        "id": 98979,
        "text": "<p><span style=\"font-size:12.0pt;\">Holmes band</span></p>"
      },
      {
        "id": 98980,
        "text": "<p><span style=\"font-size:12.0pt;\">Hall-Wellner Band</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What among the following can be employed for establishing the confidence interval in the Kaplan-Meier survival curve? </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
    "unique_key": "Q2033263",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175021,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hall-Wellner Band</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Kaplan-Meier survival curve is a graphical representation commonly used in survival analysis to display the probability of an event, typically survival, over time.</span></li><li><span style=\"font-size:12.0pt;\">It is particularly useful when studying the time to a specific event, such as death or disease progression.</span></li><li><span style=\"font-size:12.0pt;\">The Kaplan-Meier curve often incorporates bands around the survival estimate, which represent the confidence interval.</span></li><li><span style=\"font-size:12.0pt;\">Hall-Wellner bands, Gill bands, and Nair's Equal Precision confidence bands are used for this purpose.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/psm.jpg\" alt=\"\" width=\"400\" height=\"361\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Unequal precision band:</strong> Not a standard term used for Kaplan-Meier survival curves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hirshberg band:</strong> Not a recognized method for establishing confidence intervals in Kaplan-Meier survival curves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Holmes band:</strong> Not a recognized method for establishing confidence intervals in Kaplan-Meier survival curves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Hall-Wellner band is employed for establishing the confidence interval in the Kaplan-Meier survival curve, providing a visual representation of the variability and confidence in the survival estimates.</span></li></ul>",
    "correct_choice_id": 98980,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 44300,
    "choices": [
      {
        "id": 176851,
        "text": "<p><span style=\"font-size:12.0pt;\">Tablet-based software</span></p>"
      },
      {
        "id": 176852,
        "text": "<p><span style=\"font-size:12.0pt;\">TV-based software</span></p>"
      },
      {
        "id": 176853,
        "text": "<p><span style=\"font-size:12.0pt;\">Digital weighing machine</span></p>"
      },
      {
        "id": 176854,
        "text": "<p><span style=\"font-size:12.0pt;\">Telephone-based software</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the \"ANMOL\" Program for auxiliary nurse midwives?</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q7088391",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175005,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tablet-based software</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">\"ANMOL\" is an abbreviation that stands for \"<strong>ANM</strong> (Auxiliary Nurse Midwife) <strong>ON</strong>line.\" It is a tablet-based software or online monitoring tool (for RCH portal) that is specifically designed for use by auxiliary nurse midwives (ANMs).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ANMOL program allows ANMs to register and track high-risk pregnancies, monitor children with low birth weight, and manage data related to their work at the sub-center level. It serves as a comprehensive monitoring and data management tool for ANMs, enabling them to efficiently carry out their responsibilities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"ANMOL\" program is a tablet-based software or online monitoring tool specifically designed for auxiliary nurse midwives (ANMs) to register and track high-risk pregnancies, monitor children with low birth weight, and manage data at the sub-center level.</span></p>",
    "correct_choice_id": 176851,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10136,
    "choices": [
      {
        "id": 40510,
        "text": "<p><span style=\"font-size:12.0pt;\">ANOVA is an example of a non-parametric test</span></p>"
      },
      {
        "id": 40511,
        "text": "<p><span style=\"font-size:12.0pt;\">It is used for skewed distributions</span></p>"
      },
      {
        "id": 40512,
        "text": "<p><span style=\"font-size:12.0pt;\">It involves the assumption that the data has a normal distribution</span></p>"
      },
      {
        "id": 40513,
        "text": "<p><span style=\"font-size:12.0pt;\">It cannot be used for small sample sizes</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true for non-parametric tests? (NEET PG 2018)</span></p>",
    "unique_key": "Q8490679",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175011,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) It is used for skewed distributions</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-parametric tests are statistical tests that do not require the data to be normally distributed or have a specific population parameter, such as the mean or variance, assumed beforehand. They are typically used when the data are not normally distributed, have outliers, or when the sample size is small.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Some examples of non-parametric tests include the Wilcoxon rank-sum test, Kruskal-Wallis test, and Mann-Whitney U test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ANOVA is an example of a non-parametric test:&nbsp;</strong> Is incorrect because<strong> ANOVA</strong> is a parametric test used to compare the means of two or more groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It involves the assumption that the data has a normal distribution:</strong> Is incorrect because non-parametric tests do not assume that the data has a normal distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It cannot be used for small sample sizes:</strong> Is also incorrect because non-parametric tests can be used for small sample sizes. In fact, they are often preferred over parametric tests for small sample sizes or when the assumptions of parametric tests are violated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Non-parametric tests are valuable statistical tools when dealing with skewed distributions or when the assumptions of parametric tests (like normal distribution) are not met. They provide robustness against the distribution shape of the data and are effective in handling smaller sample sizes and outliers.</span></p>",
    "correct_choice_id": 40511,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 46425,
    "choices": [
      {
        "id": 185319,
        "text": "<p><span style=\"font-size:12.0pt;\">80/lac LB</span></p>"
      },
      {
        "id": 185320,
        "text": "<p><span style=\"font-size:12.0pt;\">60/lac LB</span></p>"
      },
      {
        "id": 185321,
        "text": "<p><span style=\"font-size:12.0pt;\">70/lac LB</span></p>"
      },
      {
        "id": 185322,
        "text": "<p><span style=\"font-size:12.0pt;\">90/lac LB</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Under the sustainable development goal given by United Nations target for reduction of MMR by the year 2030 is&nbsp;</span>(FMGE JULY 2023)</p>",
    "unique_key": "Q4852302",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175039,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 70/lac LB</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The United Nations has set 17 Sustainable Development Goals (SDGs) to be achieved by 2030.</span></li><li><span style=\"font-size:12.0pt;\">Goal number 3, which is directly health-related, focuses on \"Health and well-being for all.\" Under this goal \u2013&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Target 3.1 specifically states that the Maternal Mortality Rate (MMR) should be reduced below 70 maternal deaths per 1 lakh live births by 2030.</span></li><li><span style=\"font-size:12.0pt;\">Target 3.2 \u2013 U5MR &lt;25 per 1 lakh live births by 2030.</span><br><span style=\"font-size:12.0pt;\">-&nbsp; NNMR &lt;12 per 1000 live births</span></li></ul></li></ul><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The United Nations' Sustainable Development Goal target 3.1 aims to reduce the global Maternal Mortality Rate (MMR) to below 70 maternal deaths per 1 lakh (100,000) live births by the year 2030.</span></p>",
    "correct_choice_id": 185321,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 49025,
    "choices": [
      {
        "id": 195675,
        "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline alone</span></p>"
      },
      {
        "id": 195676,
        "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline + Azithromycin</span></p>"
      },
      {
        "id": 195677,
        "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone + Doxycycline</span></p>"
      },
      {
        "id": 195678,
        "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone alone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old farmer reports symptoms of fever, body pain, and a cough. A physical examination reveals a black lesion as depicted in the accompanying image. Laboratory tests confirm the presence of IgM antibodies indicative of Scrub Typhus infection. What treatment approach would be most advisable in this case? (</span><span style=\"font-size:11.0pt;\">INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/13/screenshot-2024-06-13-111337.JPG\" alt=\"\" width=\"300\" height=\"175\"></span></p><p>&nbsp;</p>",
    "unique_key": "Q2623036",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175002,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Doxycycline alone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This black lesion is Eschar and this is the acute case of Scrub Typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Causative organism - Rickettsia tsutsugamushi; Vector - Mite</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred approach depends on the severity of the condition and individual patient considerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Doxycycline Alone</strong>:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Use</strong>: This is the first-line treatment for Scrub Typhus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mechanism</strong>: Doxycycline works by inhibiting protein synthesis in bacteria, effectively controlling the infection.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Why Prefer</strong>: It's highly effective and typically well-tolerated, making it suitable for most cases unless contraindicated.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Doxycycline + Azithromycin</strong>: Used when there is co-infection with other pathogens that azithromycin can cover or when doxycycline alone isn't adequately effective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ceftriaxone + Doxycycline</strong>: This combination might be used in more severe cases or when the patient has complications that might benefit from a broader antibiotic coverage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ceftriaxone Alone</strong>: While effective against many types of bacteria, it's not the targeted treatment for Scrub Typhus and generally not recommended unless other options are contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective </strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Doxycycline alone is usually sufficient and most advisable for uncomplicated Scrub Typhus. Combination therapies may be considered in specific clinical scenarios where co-infections or severe presentations are evident.</span></p>",
    "correct_choice_id": 195675,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 11165,
    "choices": [
      {
        "id": 44626,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence increases and prevalence reduces</span></p>"
      },
      {
        "id": 44627,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence remains the same</span></p>"
      },
      {
        "id": 44628,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence remains the same and prevalence increases</span></p>"
      },
      {
        "id": 44629,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A team of oncologists is implementing a new treatment strategy for metastatic melanoma that significantly improves overall survival rates for patients. How would you categorize the change in incidence and prevalence of metastatic melanoma in the population treated at this center? (INICET NOV 2020)</span></p>",
    "unique_key": "Q5482403",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175016,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Incidence remains the same and prevalence increases</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given scenario shows that there is a new treatment which can extend overall survival but cannot cure a particular disease.</span></li><li><span style=\"font-size:12.0pt;\">So, old cases will live longer and thus, there will be increase in prevalence. Incidence will not get affected due to this.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Incidence increases and prevalence reduces:</strong> Incorrect as the new treatment does not affect the number of new cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Incidence reduces and prevalence remains the same:</strong> Incorrect because the incidence is unaffected by treatment, and the prevalence would increase due to longer survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Incidence reduces and prevalence increases:</strong> Incorrect because the incidence remains the same.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>PREVALENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Total current (Old + New) cases in a given population over.</span></li><li><span style=\"font-size:12.0pt;\">Prevalence = Incidence \u00d7 Mean duration of disease [P = I \u00d7 d]</span></li><li><span style=\"font-size:12.0pt;\">Prevalence describes the balance between incidence, mortality and recovery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>INCIDENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Number of new cases occurring in a defined population over a specified period of time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note - A treatment that extends the lives of patients with a chronic condition will increase prevalence, even if incidence remains stable.</strong></span></p>",
    "correct_choice_id": 44628,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11096,
    "choices": [
      {
        "id": 44350,
        "text": "<p><span style=\"font-size:12.0pt;\">Onset of symptoms</span></p>"
      },
      {
        "id": 44351,
        "text": "<p><span style=\"font-size:12.0pt;\">Onset of pathological changes</span></p>"
      },
      {
        "id": 44352,
        "text": "<p><span style=\"font-size:12.0pt;\">Usual time of diagnosis</span></p>"
      },
      {
        "id": 44353,
        "text": "<p><span style=\"font-size:12.0pt;\">Exposure to etiologic agent</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What importance does the point labelled as 'C' hold? (INICET MAY 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip17.jpg\" alt=\"\" width=\"500\" height=\"200\"></p>",
    "unique_key": "Q6326023",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175040,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Onset of symptoms</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given image depicts timeline of natural history of disease in an individual over time, in which the point labelled C denotes the onset of symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip18.jpg\" alt=\"\" width=\"700\" height=\"344\"></span></p><p>&nbsp;</p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Natural history of disease describes the natural course of the disease from its early pre pathogenesis phases to termination.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture6555_HE1z4lo.jpg\" alt=\"\" width=\"800\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The onset of symptoms marks the transition from the subclinical stage to the clinical stage of disease.</span></li></ul>",
    "correct_choice_id": 44350,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 10468,
    "choices": [
      {
        "id": 41838,
        "text": "<p><span style=\"font-size:12.0pt;\">Panel discussion</span></p>"
      },
      {
        "id": 41839,
        "text": "<p><span style=\"font-size:12.0pt;\">Symposium</span></p>"
      },
      {
        "id": 41840,
        "text": "<p><span style=\"font-size:12.0pt;\">Workshop</span></p>"
      },
      {
        "id": 41841,
        "text": "<p><span style=\"font-size:12.0pt;\">Seminar</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In a tertiary care hospital, health professionals gather to observe WHO Day. An event features 4-8 experts seated in front of an audience. The Director starts with a welcome and introduction, then invites speakers to share their perspectives without a set order or structured presentation. Audience participation is encouraged at the end. How would you categorize this mode of interaction? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q9167077",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175028,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Panel discussion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Panel discussion</strong> takes place between experts on a common topic. There is no structure/order and it takes place in front of an audience.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-163233.jpg\" alt=\"\" width=\"700\" height=\"1086\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Symposium:</strong> There is no discussion between experts, there are lectures set in series in front of an audience.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong>&nbsp;<strong>Workshop:</strong> Involves hands on training in order to attain skills.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Seminars:</strong> Take place on a specific topic/theme for 6-8 hours/day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A panel discussion is characterized by unstructured, spontaneous interaction among experts in front of an audience, with opportunities for audience engagement.</span></p>",
    "correct_choice_id": 41838,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 11136,
    "choices": [
      {
        "id": 44510,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/2 protein and 1/3 calorie requirements</span></p>"
      },
      {
        "id": 44511,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/3 protein and 1/3 calorie requirements</span></p>"
      },
      {
        "id": 44512,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/2 protein and 1/2 calorie requirements</span></p>"
      },
      {
        "id": 44513,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/3 protein and 1/2 calorie requirements</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following best describes the nutritional targets of Mid-Day Meal Program,</span><span style=\"color:black;font-size:12.0pt;\"> as per the Indian government guidelines? </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2018)</span></p>",
    "unique_key": "Q3890930",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175001,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 1/2 protein and 1/3 calorie requirements</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The meal should supplement 1/3 of the total energy requirement and 1/2 of the total protein requirement.</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal programme (MDMP):</strong> Also known as \u2018School Lunch Programme\u2019, it has been in operation since 1961.</span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">The <strong>major objective</strong> of MDMP: To attract more children for admission to schools and retain them so that literacy improvement of children could be brought about.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal is a supplement and not a substitute to the home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">MDMP is being operationalised under the Ministry of Human Resource &amp; Development&nbsp;</span></li><li><span style=\"color:black;font-size:12.0pt;\">National Institute of Nutrition, Hyderabad is of the view that minimum number of feeding days in year be 250 to have the desired impact on children</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal scheme (MDMS) (National Programme of Nutritional Support to Primary Education):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Launched in 1995</span></li><li><span style=\"color:black;font-size:12.0pt;\">Main objective: Universalisation of primary education by increasing enrolment, retention and attendance and simultaneously impacting on nutrition of students in primary classes</span></li><li><span style=\"color:black;font-size:12.0pt;\">The mid-day meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">A model menu for mid-day school meal -</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture22333.jpg\" alt=\"\" width=\"700\" height=\"422\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Principles for formulating mid-day meals:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Meal should be a supplement only not a substitute for home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal should provide 1/3 calories and 1/2 proteins</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal cost should be low</span></li><li><span style=\"color:black;font-size:12.0pt;\">Complicated cooking process must not be involved</span></li><li><span style=\"color:black;font-size:12.0pt;\">Use locally available foods</span></li><li><span style=\"color:black;font-size:12.0pt;\">Keep changing menu frequently</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-Day Meal Scheme is now renamed as PM POSHAN or Pradhan Mantri Poshan Shakti Nirman.</strong></span></p>",
    "correct_choice_id": 44510,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  }
];
        let quizName = 'Late Night Pyq:Pyt (Psm-3)';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>